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Abstract To maintain cellular structure and integrity during division, Gram-negative bacteria must
carefully coordinate constriction of a tripartite cell envelope of inner membrane, peptidoglycan (PG),
and outer membrane (OM). It has remained enigmatic how this is accomplished. Here, we show that
envelope machines facilitating septal PG synthesis (PBP1B-LpoB complex) and OM constriction
(Tol system) are physically and functionally coordinated via YbgF, renamed CpoB (Coordinator of PG
synthesis andOM constriction, associated with PBP1B). CpoB localizes to the septum concurrent with
PBP1B-LpoB and Tol at the onset of constriction, interacts with both complexes, and regulates PBP1B
activity in response to Tol energy state. This coordination links PG synthesis with OM invagination and
imparts a unique mode of bifunctional PG synthase regulation by selectively modulating PBP1B cross-
linking activity. Coordination of the PBP1B and Tol machines by CpoB contributes to effective PBP1B
function in vivo and maintenance of cell envelope integrity during division.
DOI: 10.7554/eLife.07118.001
Introduction
Cell shape and osmotic stability are maintained by the stress-bearing peptidoglycan (PG) sacculus (cell
wall) in nearly all bacteria (Vollmer et al., 2008). The sacculus, a continuous mesh-like structure of glycan
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strands cross-linked by short peptides, encases the inner (cytoplasmic) membrane (IM) and is essential
for viability. Several prominent classes of antibiotics (e.g., β-lactams and glycopeptides) inhibit PG
synthesis, causing lysis and cell death (Schneider and Sahl, 2010). In Gram-negative bacteria, the outer
membrane (OM), an asymmetric bilayer of phospholipids and lipopolysaccharides, surrounds the mostly
single-layered sacculus (Gan et al., 2008) and forms a vital permeability barrier (Nikaido, 2003).
Covalent and non-covalent interactions between abundant OM proteins (Lpp, Pal, OmpA) and PG
tether the OM to the sacculus, maintaining OM stability (Hantke and Braun, 1973; Parsons et al.,
2006). Together, the IM, PG, and OM comprise the tripartite Gram-negative cell envelope (Figure 1A).
Bacteria must synchronize growth and division of these layers, as imbalanced growth could lead to
breaches that compromise the permeability barrier or even the structural integrity of the cell. However,
we do not yet understand the mechanisms that accomplish this synchronization.
Coordinating growth across the layers of the Gram-negative bacterial cell envelope is complex,
particularly since all energy and precursors for assembling and constricting these layers must come
from the cytoplasm. To overcome this challenge, bacteria utilize IM-associated multicomponent
machineries that span the entire envelope. Two machineries, organized by distinct cytoskeletal
elements, assemble and disassemble in a cell-cycle-regulated manner and mediate different phases of
sacculus growth (Typas et al., 2012): (1) the cell elongation machinery (elongasome), organized by
the actin homolog MreB, mediates lateral PG synthesis along the length of the cell, and (2) the cell
division machinery (divisome), organized by the tubulin homolog FtsZ, mediates new pole synthesis at
the septum (Egan and Vollmer, 2013). These complex machineries are comprised of structural and
regulatory subunits, components with distinct functions (e.g., DNA segregation, PG precursor
synthesis and transport), and PG biosynthetic and modifying enzymes.
Sacculus growth is orchestrated by a repertoire of PG synthases, including glycosyltransferases
(GTases) that polymerize glycan strands from the precursor saccharide moiety lipid II, transpeptidases
(TPases) that cross-link peptides between adjacent glycan strands, and bifunctional PG synthases that
carry out both activities (Typas et al., 2012). The two Escherichia coli monofunctional TPases, PBP2,
and PBP3, are essential subunits of the elongasome and the divisome, respectively. Likewise, the two
major bifunctional PG synthases, PBP1A and PBP1B, participate predominantly in elongation and
eLife digest All bacterial cells are surrounded by a membrane, which forms a protective barrier
around the cell. Most bacteria also have a wall surrounding the membrane, which provides structural
support. When a bacterial cell divides to produce two daughter cells, it produces a belt-like structure
around the middle of the cell. This brings the membrane and cell wall on each side together to
a ‘pinch-point’ until the two halves of the cell have been separated. This process must be carefully
controlled to ensure that the cell does not burst open at any point.
Some bacteria known as ‘Gram-negative’ bacteria have a second membrane on the other side of
the cell wall. These cells divide in the same way as other bacteria, but the need to coordinate the
movement of three structures instead of two makes it more complicated. Many proteins are known
to be involved. For example, one group (or ‘complex’) of proteins—which includes a protein called
PBP1B—helps to produce new cell wall material. Another complex called the Tol system provides the
energy needed for the outer membrane to be pulled inwards towards the pinch point. However, it
has not been clear how these complexes work together to allow the cell to divide.
Here, Gray, Egan et al. searched for proteins that can interact with PBP1B during cell division in
the Gram-negative bacterium E. coli. The experiments found that a protein called CpoB interacts
with both PBP1B and the Tol system. CpoB is found in a band around the middle of the cell, and it
regulates the activity of PBP1B in response to signals from the Tol system. If the activity of CpoB is
disrupted, cell wall production and the movement of the outer membrane are no longer coordinated,
and the membrane falls apart, leading to the death of the bacteria.
Gray, Egan et al.’s findings show how the production of new cell wall material can be linked to the
inwards movement of the outer membrane during cell division. The next challenges are to
understand the precise details of how these processes are coordinated by CpoB and to find out
whether CpoB also plays the same role in other bacteria.
DOI: 10.7554/eLife.07118.002
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division, respectively (Bertsche et al., 2006; Typas et al., 2010; Banzhaf et al., 2012). However, in
contrast to the monofunctional TPases, which are dedicated to their respective roles, the bifunctional
synthases can partially substitute for each other, enabling cells to survive with only one of them
(Yousif et al., 1985). These IM-localized bifunctional synthases have obligate cognate regulatory OM
lipoproteins, LpoA and LpoB, which are required for activity in vivo (Paradis-Bleau et al., 2010; Typas
et al., 2010). The Lpo activators span most of the periplasm (∼210 A˚ in width;Matias et al., 2003) and
traverse the sacculus (∼40–60 A˚ pore size; Demchick and Koch, 1996; Vazquez-Laslop et al., 2001)
to interact with their partner PBPs (Egan et al., 2014; Jean et al., 2014), forming trans-envelope PG
synthase complexes (Figure 1B).
Electron microscopy studies first indicated that distances between the OM, PG, and IM remain
remarkably consistent throughout cell division, providing an early indication that envelope
constriction processes occur in close proximity to each other and are tightly coordinated (Weigand
et al., 1976; Fung et al., 1978;MacAlister et al., 1987; Bi and Lutkenhaus, 1991). It is now clear that
IM constriction, PG synthesis, and subsequent PG hydrolysis to separate daughter cells (septal
cleavage) are coordinated via the divisome. FtsZ forms a ring-like structure in the cytoplasm that
provides the membrane contractile force (Osawa et al., 2009), and together with FtsA (Szwedziak
et al., 2012;Osawa and Erickson, 2013; Loose and Mitchison, 2014; Szwedziak et al., 2014) serves
as a scaffold for divisome assembly, including recruitment of PG synthases and hydrolases (Egan and
Vollmer, 2013). Septal PG synthesis, principally orchestrated by PBP3 and PBP1B (Bertsche et al.,
2006), occurs at the leading edge of the inward-moving septum, adjacent to the invaginating IM
(Figure 1A). Septal cleavage, controlled by tightly regulated periplasmic amidases (Heidrich et al.,
2001; Uehara et al., 2010), follows closely after synthesis and adjacent to the invaginating OM. Both
topological constraints and regulatory input from IM and/or OM proteins ensure tight spatial
regulation of septal cleavage (Uehara et al., 2010; Yang et al., 2011).
OM constriction is promoted by the energy-transducing Tol system, which localizes to mid-cell
during the later stages of cell division in a divisome-dependent manner (Gerding et al., 2007). IM
proteins TolQ, TolR, and TolA, which form a complex (Derouiche et al., 1995; Lazzaroni et al., 1995;
Journet et al., 1999), periplasmic TolB, and OM lipoprotein Pal are all encoded in two adjacent
Figure 1. Envelope constriction in Gram-negative bacteria and related protein machines. (A) Illustration of the
tripartite Gram-negative cell envelope. In zoom (right), processes involved in envelope constriction. (B) Major
bifunctional PG synthases of E. coli, capable of both glycan strand elongation (glycosyltransferase activity, GT) and
peptide cross-linking (transpeptidase activity, TP). The IM-localized synthases are activated by cognate regulatory
OM lipoproteins. (C) Proteins encoded by the tol-pal operons (D).
DOI: 10.7554/eLife.07118.003
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operons (Figure 1C,D). Loss of any of these components results in delayed OM constriction and
defects in OM integrity, leading to OM blebbing, periplasmic leakage, and pleiotropic drug and stress
sensitivities (Bernadac et al., 1998; Cascales et al., 2002; Gerding et al., 2007). For function, Tol
harnesses proton motive force (PMF) via TolQR, a homolog of the flagellar motor MotAB (Cascales
et al., 2001). This has been proposed to energize TolA, inducing it to adopt an extended
conformation and interact with TolB and/or Pal (Cascales et al., 2000; Germon et al., 2001; Lloubes
et al., 2001); cycles of Tol–Pal interaction and release are then thought to promote OM invagination
(Gerding et al., 2007). This interaction model has been challenged, however (Bonsor et al., 2009),
and the mechanism by which the Tol system promotes OM constriction remains to be fully elucidated.
Further, how Tol-facilitated OM constriction is coordinated with septal PG synthesis and other
envelope constriction processes has remained completely unknown.
We previously identified a genetic link between PBP1B-LpoB and Tol (Typas et al., 2010). Here, we
report that physical and functional coordination of the two machines is required to properly
synchronize PG synthesis and OM constriction during cell division. We implicate YbgF, previously of
unknown function, in mediating this coordination, and therefore name it CpoB, or Coordinator of PG
synthesis and OM constriction, associated with PBP1B. We show that CpoB, PBP1B-LpoB, and Tol
localize concurrently to the septum during cell division, and interact to form a higher-order complex
that spatially links PG synthesis and OM invagination. These physical interactions are dynamic and
allow direct regulation of PBP1B activity in response to Tol assembly and cycles of PMF utilization.
CpoB is required for proper PBP1B function in vivo, and loss of CpoB-mediated coordination between
PBP1B and Tol leads to defects in OM integrity, illustrating the importance of mechanisms that ensure
coordination of cell division processes across the envelope.
Results
The auxiliary Tol-associated protein CpoB has a PBP1B-associated
function
To identify novel regulators of PG synthesis during cell division, we queried the E. coli chemical
genomics database (Nichols et al., 2011) for deletion strains whose growth responses closely
resembled those of a strain lacking PBP1B (encoded by mrcB) across a range of drug and
environmental stress conditions. This approach previously identified LpoB, the OM lipoprotein
activator of PBP1B (Typas et al., 2010). ΔcpoB exhibited the second highest correlation with ΔmrcB
(Figure 2A; correlation coefficient = 0.47, p < 10−18), suggesting that CpoB may also be functionally
associated with PBP1B. CpoB (YbgF) is encoded by the last gene in the tol-pal operon and binds TolA
in vitro (Krachler et al., 2010), but its deletion does not cause the severe OM integrity defects
typically associated with tol-pal deletions (Vianney et al., 1996). Thus, CpoB is not critical for Tol
function, and its cellular role has remained enigmatic.
ΔcpoB and ΔmrcB mutants shared increased sensitivities to multiple β-lactams (Figure 2A),
including cefsulodin, which preferentially inhibits PBP1A. As loss of both PBP1A and PBP1B function is
synthetically lethal (Yousif et al., 1985), the enhanced cefsulodin sensitivity of ΔcpoB likely derives
from defects in PBP1B function. Consistent with this idea, overexpression of PBP1B abrogated the
cefsulodin sensitivity of ΔcpoB (Figure 2B). Additionally, both ΔcpoB and ΔmrcB mutants exhibited
increased lysis in an envelope stability screen (Paradis-Bleau et al., 2014). Importantly, the lysis
phenotype of ΔcpoB ΔmrcB did not exceed that of the ΔmrcB single mutant (Figure 2—figure
supplement 1A,B). This epistatic relationship strongly suggests that CpoB acts via PBP1B. Expression
of CpoB in trans complemented ΔcpoB phenotypes, confirming that they result from loss of CpoB
rather than indirect effects on upstream tol-pal gene expression (Figure 2—figure supplement 2).
Having established a functional relationship between CpoB and PBP1B, we asked whether they interact
physically in vivo. Indeed, we identified CpoB in a screen for novel PBP1B interaction partners, using in vivo
photo-cross-linking following incorporation of a non-natural amino acid (pBpa) at specific exposed sites
(Chin and Schultz, 2002). Initially focusing on the PBP1B UB2H domain, we identified two sites (T118 and
E123), of 19 examined, that cross-linked to a protein of approximately 30 kDa (Figure 3A,B). These sites
reside in a cleft between the UB2H and TPase domains. Testing opposing amino acids in the TPase
domain (T751 and T753) yielded cross-link products of the same size (Figure 3A,B). Mass spectrometric
analysis of the cross-link bands identified CpoB as a main constituent of the cross-linking product (Table 1).
These results imply that PBP1B and CpoB physically interact in vivo.
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Figure 2. Shared chemical sensitivities and genetic interactions implicate CpoB in PBP1B function. (A) Chemical
genetic phenotype profiles for strains lacking PBP1B (encoded by mrcB), LpoB, and CpoB, from hierarchical
clustering of the growth fitnesses of 3979 gene deletions across 324 chemical stress conditions (Nichols et al.,
2011). Blue, low fitness (sensitivity); yellow, high fitness (resistance). ΔmrcB and ΔcpoB (ΔybgF) showed
significant similarity. Underlined regions correspond to strongest shared sensitivities and are magnified below
the full profile. (B) Sensitivity of ΔcpoB to cefsulodin, predominantly an inhibitor of PBP1A, is alleviated by
PBP1B overexpression. Growth fitness was assessed by pinning cells to agar plates in a 1536-spot format and
quantifying colony size after 12–14 hr of growth. Error bars depict standard deviations (n ≥ 44). (C) CpoB-
associated envelope defects visualized by fluorescence microscopy using periplasmic mCherry. Arrowheads,
fluorescent foci indicating OM blebs or vesicles; outlines, loss of peripheral fluorescence due to periplasmic
leakage. (D) and (E). Quantification of microscopy phenotypes: (D) OM blebbing, and (E) loss of periplasmic
fluorescence, indicative of periplasmic leakage. Threshold value was established based on quantification of cells
with known severe OM defects (ΔtolA). Cells lacking CpoB exhibited envelope defects that were severely
exacerbated in the absence of LpoA and alleviated by PBP1B overexpression. (F) Quantification of growth
Figure 2. continued on next page
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Genetic interactions further implicate CpoB in PBP1B function and reveal
a CpoB-related function for LpoA
If CpoB contributes to PBP1B function, then absence of PBP1A or its required activator LpoA
(Paradis-Bleau et al., 2010; Typas et al., 2010) should result in an aggravated phenotype
(Figure 2—figure supplement 3C). Consistent with this expectation, a strain lacking both CpoB and
LpoA showed a severe growth defect (Figure 2F). To our surprise, however, a strain lacking both
CpoB and PBP1A grew normally (Figure 2—figure supplement 3A). We tracked down the reason for
this discrepancy to a previously unknown function of LpoA. LpoA possesses two-domains, an
N-terminal tetratricopeptide repeat (TPR) domain and a C-terminal domain (Figure 2—figure
supplement 4A). The C-terminal domain is sufficient to bind and activate PBP1A in vitro (Typas et al.,
2010; Jean et al., 2014) and, we show here, in vivo (Figure 2—figure supplement 3B). We found that
the N-terminal TPR domain encodes an additional function that can compensate for loss of CpoB.
As evidence, though a ΔcpoB ΔmrcA mutant has no growth defect, a triple mutant also lacking the
LpoA TPR domain, ΔcpoB ΔmrcA lpoA(ΔTPR), recapitulates the growth defect of the ΔcpoB ΔlpoA
mutant (Figure 2—figure supplement 4D). Importantly, this CpoB compensatory function of LpoA is
required only when PBP1B is the sole active bifunctional synthase, as a ΔcpoB lpoA(ΔTPR) mutant
(in which PBP1A is active) grows normally (Figure 2—figure supplement 4D).
To further assess the importance of CpoB function for envelope integrity, we used periplasmic
mCherry to fluorescently visualize envelope morphology (Gerding et al., 2007). Both ΔmrcB and
ΔcpoB strains exhibited minor OM defects, including elevated levels of OM blebbing (Figure 2C,E).
As with the growth phenotype, these ΔcpoB envelope defects were greatly exacerbated in the
absence of LpoA, with extensive OM blebbing, periplasmic leakage and cell lysis (Figure 2C,E and
Figure 2—figure supplement 1A–C). All of these effects were recapitulated in a ΔcpoB ΔmrcA lpoA
(ΔTPR) triple mutant (Figure 2—figure supplement 4B–D), and ameliorated by overexpression of
PBP1B (Figure 2C–F and Figure 2—figure supplement 4B–D). Of note, the envelope defects of
ΔcpoB ΔlpoA were distinct from those of tol-pal mutants (Gerding et al., 2007), with more extensive
lysis but less OM blebbing and periplasmic leakage (Figure 2C–E and Figure 2—figure supplement 1C).
Taken together, these results validate further that CpoB contributes to proper PBP1B function in
vivo; indicate that this function is important for envelope integrity, and particularly important when
cells must rely on PBP1B; and serendipitously reveal a partial redundancy of function between CpoB
and the LpoA TPR domain.
CpoB localizes to the septum late in cell division, coincident with the
onset of OM constriction
We next investigated whether CpoB, like PBP1B and Tol (Bertsche et al., 2006; Gerding et al.,
2007), is recruited to the septum. Using a functional, endogenously expressed CpoB-mCherry fusion
protein (Figure 4—figure supplement 1A), we observed that CpoB localized at sites of visible
Figure 2. Continued
fitness for indicated mutant strains. A strain lacking CpoB and LpoA exhibited a synthetic growth defect that was
alleviated by PBP1B overexpression.
DOI: 10.7554/eLife.07118.004
The following figure supplements are available for figure 2:
Figure supplement 1. Elevated cell lysis in cells lacking PBP1B or CpoB; loss of LpoA exacerbates lysis in the
absence of CpoB.
DOI: 10.7554/eLife.07118.005
Figure supplement 2. Complementation of ΔcpoB phenotypes.
DOI: 10.7554/eLife.07118.006
Figure supplement 3. LpoA encodes a second function, and the LpoA TPR domain is dispensable for PBP1A
activation.
DOI: 10.7554/eLife.07118.007
Figure supplement 4. The N-terminal TPR domain of LpoA encodes a novel function that compensates for loss of
CpoB.
DOI: 10.7554/eLife.07118.008
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envelope constriction in pre-divisional cells
(Figure 4A) and was positioned preferentially at
mid-cell with increasing prevalence as the cell
cycle progressed (Figure 4B,C). This pattern of
localization was corroborated for the native
protein, as visualized by immunolabeling cells
with antibody specific to CpoB (Figure 4—figure
supplement 2). Mid-cell positioning of CpoB-
mCherry was coincident with envelope constric-
tion (Figure 4A–D), suggesting a role during that
stage of cell division.
Tol localizes at constriction sites during later
stages of cell division (Gerding et al., 2007).
To better define the timing of CpoB recruitment,
we compared the cell cycle dynamics of septal
CpoB-mCherry localization with those of other
divisome components (Figure 4B,D). As cell
length correlates with cell cycle progression,
measuring fluorescence enrichment at mid-cell
in cells sorted by length provides a quantitative
metric for temporal comparison (den Blaauwen
et al., 1999; Aarsman et al., 2005; van der
Ploeg et al., 2013). FtsZ initiates cell division and
divisome assembly, with PBP3 and FtsN local-
izing at progressively later stages (van der Ploeg
et al., 2013; Figure 4B,D; Figure 4—figure
supplement 3); FtsN is the last essential compo-
nent recruited in the divisome (Aarsman et al.,
2005). CpoB-mCherry, a functional TolA-GFP
fusion (Figure 4—figure supplement 1B),
PBP1B, LpoB, and FtsN localized at approxi-
mately the same time (Figure 4B,D). Thus, CpoB
is recruited to the septum during the later stages
of cell division, concurrent with Tol, PBP1B, and
the onset of OM constriction.
We next asked which proteins and cell division
events are required for recruitment of CpoB to
the septum. CpoB failed to localize in cells with
temperature-sensitive (ts) FtsZ, FtsA, FtsW, or
PBP3 under non-permissive conditions, and in
cells depleted for FtsN, indicating that CpoB
localization is dependent on divisome assembly
(Figure 4—figure supplement 4A–F). CpoB also
failed to localize following inhibition of PBP3 with aztreonam (Figure 4—figure supplement 4G),
indicating that its localization also requires ongoing septal PG synthesis. However, CpoB localized
normally in the absence of PBP1B (Figure 4—figure supplement 5A). TolA dependence was more
difficult to examine, since delayed OM constriction in the absence of TolA leads to the non-specific
accumulation of periplasmic proteins at cell division sites (Gerding et al., 2007). Under growth
conditions that minimized this effect, CpoB continued to localize in the absence of TolA
(Figure 4—figure supplement 5B), suggesting that it can be recruited independently of TolA.
Because a strain lacking PBP1B and TolA is only marginally viable (Typas et al., 2010), we cannot
distinguish whether CpoB localization is independent of both PBP1B and TolA, or whether each
partner alone is sufficient to drive CpoB localization.
CpoB localization is thus tied to cell division. Further, CpoB interacts and co-localizes with proteins
involved in both OM constriction (TolA; Krachler et al., 2010; Gerding et al., 2007) and PG septal
Figure 3. PBP1B interacts with CpoB in vivo. (A) Photo-
cross-linkable amino acid (pBpa) substitutions at the
indicated positions in His6-PBP1B, lining a cleft between
the TPase and UB2H domains, formed similar UV cross-
linking products in vivo. (B) SDS-PAGE and α-His6
immunoblot analysis revealed a cross-linked adduct
∼120 kDa in size (MW of PBP1Bγ = 88.9 kDa). Analysis of
the products by mass spectrometry revealed the
presence of CpoB (MW = 28.2 kDa) cross-linked to
PBP1B at each indicated position.
DOI: 10.7554/eLife.07118.009
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 7 of 29
Research article Microbiology and infectious disease
synthesis (PBP1B; Figure 3), raising the possibil-
ity that CpoB participates in coupling these
processes following recruitment to the septum
during cell division.
CpoB, TolA, PBP1B, and LpoB form
a complex
Interactions between TolA and CpoB (Krachler
et al., 2010) and between PBP1B and LpoB
(Paradis-Bleau et al., 2010; Typas et al., 2010;
Egan et al., 2014) have been previously
reported. We searched for associations between
these complexes that might facilitate functional
coordination by testing for further direct pairwise
interactions between these proteins in vitro. As
measured by surface plasmon resonance (SPR),
CpoB bound to immobilized PBP1B with an
apparent dissociation constant (KD) of 102 ± 21
nM, but not to PBP1A or to a surface without
protein (Figure 5A,B), indicating a direct and specific interaction. CpoB is a trimer under the
conditions used (Krachler et al., 2010), but it is unclear whether CpoB binds as a monomer and/or
trimer to PBP1B. PBP1B and TolA also interact directly, as untagged TolA was retained on Ni-NTA
beads in the presence but not absence of His6-PBP1B (Figure 5C). A purified soluble version of TolA
lacking its transmembrane anchor (domain I) was not pulled down with His6-PBP1B (Figure 5C),
suggesting that domain I of TolA is important for the interaction. In contrast, LpoB does not bind
either CpoB or TolA directly, as a His-tagged version of LpoB did not retain CpoB or TolA on Ni-NTA
beads, while retaining PBP1B as expected (Figure 5—figure supplement 1A).
To contextualize these pairwise interactions, we assessed higher order interactions. As CpoB and
TolA each interact with PBP1B, we tested whether they also form a ternary complex. Indeed,
chemically cross-linking a mixture of PBP1B, TolA, and CpoB identified a high-molecular weight
species containing all three proteins (Figure 5—figure supplement 1B). Using this technique, we did
not detect analogous high molecular weight complexes of PBP1A with TolA or CpoB
(Figure 5—figure supplement 1B), confirming that the CpoB and TolA interactions and complex
formation with PBP1B were specific. Since LpoB is required for PBP1B activation in vivo, we next
tested whether CpoB and TolA interact with PBP1B in complex with LpoB. Indeed, in the presence but
not absence of PBP1B, His-LpoB retained CpoB and TolA on Ni-NTA beads after chemical cross-
linking, indicating that LpoB-PBP1B-CpoB and LpoB-PBP1B-TolA form ternary complexes
(Figure 5—figure supplement 1A). Given that all possible ternary complexes containing PBP1B
can be formed, we propose that PBP1B, LpoB, CpoB, and TolA also form a quaternary complex.
As CpoB can form a complex with both PBP1B-LpoB and TolA, its cellular abundance might
influence which interactions occur in vivo. Using purified protein as a standard and an antibody
specific to CpoB, we determined a CpoB cellular copy number of 4550 ± 540 (n = 5) in growing cells
(Figure 5—figure supplement 2). This is similar to an estimated protein synthesis rate for CpoB of
∼5200 molecules per generation, determined via ribosome profiling (Li et al., 2014). Thus, the
abundance of CpoB significantly exceeds the ∼520 molecules of PBP1B and ∼480 molecules of TolA
synthesized per generation (Li et al., 2014). CpoB forms trimers, which disassociate to the monomeric
form when bound to TolA (Krachler et al., 2010). It is unclear in what form(s) CpoB binds to PBP1B.
Nevertheless, even in its trimeric form (∼1500 trimers), CpoB is in excess to both PBP1B and TolA and
is therefore likely able to interact constitutively with both partners.
Taken together, these data suggest that CpoB, PBP1B-LpoB, and Tol associate to form a higher-
order complex, spatially linking PG synthesis and OM constriction during cell division.
CpoB and TolA modulate PBP1B-mediated PG synthesis
We tested the effects of TolA and CpoB on PBP1B GTase and TPase activities in vitro. As measured by
consumption of fluorescently labeled lipid II substrate (Figure 6A and Figure 6—figure supplement 1A),
Table 1. His6-PBP1B pBpa—CpoB cross-linking
mass spectroscopy data
Mutant Score* Coverage† Peptides‡ PSM§
T118 300.52 19.77% 7 12
E123 79.99 11.41% 3 4
T751 79.99 11.41% 3 4
T753 301.64 19.77% 7 12
*Addition of individual scores of the ion fragmentation
spectra of the identified peptides.
†Percentage of protein sequence covered by the
identified peptides.
‡Number of unique peptides of the protein identified in
the sample.
§Number of individual spectra in which the peptides
were identified.
DOI: 10.7554/eLife.07118.010
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Figure 4. CpoB localizes to mid-cell concurrent with PBP1B, TolA, and the onset of OM constriction.
(A) Endogenously expressed CpoB-mCherry localizes to mid-cell during cell division. Left, phase contrast image;
right, mCherry fluorescence; scale bar, 2 μm. (B) Localization of CpoB-mCherry as a function of cell cycle progression
(cell length), with comparison to other proteins. PBP1B, LpoB, FtsZ, PBP3, and FtsN were visualized by
immunofluorescence using specific antibodies. Cell membranes were stained with Bodipy-12. Cell width (diameter)
was measured from phase contrast images; constant brightness along the length of the cell indicates constant
diameter, and darkening at mid-cell in longer cells indicates constriction. To generate profile maps for each protein,
fluorescence intensity profiles (integrated fluorescence as a function of cell length) were derived for >1000 individual
cell images and sorted vertically by cell length. Each horizontal line corresponds to a single cell. Y-axis scale
indicates % cell-cycle progression based on cell length. Data for FtsZ, PBP3, FtsN, and cell width have been
previously published (van der Ploeg et al., 2013) and are used here for comparisons. (C) Average distribution of
CpoB-mCherry for different cell-cycle progression age groups. Fluorescence intensity profiles were normalized by
length, then averaged and normalized to the peak local brightness for each age group. (D) Relative timing of
mid-cell recruitment for each examined protein. Initiation is based on the onset of enriched localization at mid-cell
(quantified in Figure 4—figure supplement 3A,B and van der Ploeg et al., 2013). Peak is the point in the division
cycle when maximal localization is reached.
DOI: 10.7554/eLife.07118.011
The following figure supplements are available for figure 4:
Figure supplement 1. Endogenously-encoded CpoB-mCherry and GFP-TolA fusion proteins are functional.
DOI: 10.7554/eLife.07118.012
Figure 4. continued on next page
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TolA increased the GTase rate of PBP1B 1.9 ± 0.5-fold, indicating that TolA is a novel regulator of
PBP1B. Although weaker than the eightfold stimulation by LpoB (Figure 6A; Egan et al., 2014), TolA
and LpoB stimulations were additive, together yielding an 11.3 ± 0.5-fold increase in GTase activity.
These results indicate that LpoB and TolA stimulate PBP1B GTase activity by compatible mechanisms.
In contrast, CpoB had no effect on the GTase activity of PBP1B, alone or in combination with LpoB
and/or TolA (Figure 6A). On the other hand, neither CpoB nor TolA affected basal PBP1B TPase
activity (Figure 6B, orange), as quantified by percentage of peptides with cross-links in PG produced
with radiolabelled lipid II as substrate. Note that, unlike for GTase activity, a continuous TPase assay is
currently not available, and therefore we cannot rule out that one of the two proteins affects the TPase
rate of PBP1B; this would in fact be expected for TolA as a consequence of GTase activation
(see below).
The GTase and TPase activities of PBP1B are coupled, as is generally true for bifunctional synthases
(Bertsche et al., 2005; Born et al., 2006; Lupoli et al., 2014). LpoB activates both the PBP1B GTase
domain, increasing reaction rate, and the TPase domain, thereby producing hyper-cross-linked PG
(Figure 6B, blue; Typas et al., 2010; Egan et al., 2014). Interestingly, although CpoB did not affect
the cross-linking activity of PBP1B on its own, it partially prevented the formation of hyper-cross-
linked PG in the presence of LpoB (Figure 6B, blue). As CpoB affected neither LpoB binding to PBP1B
(Figure 5—figure supplement 1A) nor GTase stimulation of PBP1B (Figure 6A), CpoB must directly
interfere with LpoB activation of the PBP1B TPase. Strikingly, TolA alleviated the inhibitory effect of
CpoB, restoring the synthesis of highly cross-linked PG in the presence of LpoB (Figure 6B, cyan).
The effect of CpoB on TPase activity was further enhanced at a moderately increased salt
concentration (215 mM NaCl), suggesting that its regulatory effect on PBP1B may be intensified under
stress. In this condition, LpoB increased cross-linking from 50% to 60%. The addition of CpoB
completely prevented this stimulation, whereas TolA again alleviated the CpoB effect (Figure 6B,
right graph). Though the magnitudes of these effects are moderate, they are likely significant in vivo
given the essentiality of LpoB for PBP1B function under all conditions tested (Paradis-Bleau et al.,
2010; Typas et al., 2010), including different salt concentrations. In summary, interaction of the
PBP1B-LpoB synthase complex with TolA further stimulates PBP1B GTase activity, and interactions
with CpoB and TolA modulate PBP1B TPase activity via reciprocal effects.
Regulation of PBP1B by CpoB and TolA responds to Tol energy state in
vivo
To establish in vivo relevance and to understand how complex formation and PBP1B activity are
regulated in vivo, we systematically characterized interactions between CpoB, TolA, PBP1B, and LpoB
via DTSSP cross-linking and co-immunoprecipitation (Figure 7A–C). In addition to the previously
reported PBP1B-LpoB pair (Typas et al., 2010), we observed specific pairwise interactions between
CpoB, TolA, and PBP1B, validating that these interactions also occur in vivo. Interestingly, CpoB
exhibited minimal or no cross-linking with LpoB in the presence of TolA, but a dramatic increase in
cross-linking in its absence (Figure 7A). Thus, TolA both prevents CpoB from associating with LpoB
(Figure 7A) and from interfering with PBP1B TPase stimulation by LpoB (Figure 6B), suggesting that
these effects are linked. Since an interaction between CpoB and LpoB was not detected in vitro
(Figure 5—figure supplement 1A), their association in vivo likely occurs in the context of the CpoB-
PBP1B-LpoB ternary complex (Figure 8A). This possibility could not be tested directly because
Figure 4. Continued
Figure supplement 2. CpoB localizes to mid-cell.
DOI: 10.7554/eLife.07118.013
Figure supplement 3. Timing of localization to mid-cell for CpoB-mCherry, GFP-TolA, and PBP1B, with comparison
to divisome proteins FtsZ, PBP3, and FtsN.
DOI: 10.7554/eLife.07118.014
Figure supplement 4. Localization of CpoB to mid-cell is dependent on divisome assembly and function.
DOI: 10.7554/eLife.07118.015
Figure supplement 5. Localization of CpoB to mid-cell is independent of PBP1B and TolA.
DOI: 10.7554/eLife.07118.016
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a strain lacking both PBP1B and TolA is only
marginally viable (Typas et al., 2010). TolA did
not prevent PBP1B from interacting with CpoB
(Figure 7A); thus, interaction with TolA may
instead alter the conformation of CpoB in
a manner that both prevents it from interacting
with LpoB (Figure 7A) and, concurrently, from
modulating PBP1B TPase activation by LpoB
(Figure 6B).
PBP1B-CpoB-TolA complex formation was
highly responsive to Tol complex status. In the
absence of TolQ, abrogating formation of the
TolQR–TolA complex, PBP1B-TolA and PBP1B-
CpoB interactions were both substantially di-
minished. In contrast, CpoB–LpoB interaction
and PBP1B-LpoB complex formation increased
significantly (Figure 7A). Together, these data
suggested that CpoB regulates PBP1B-LpoB in
response to Tol assembly state, energy state, or
both. To distinguish between these possibilities,
we compared the effects of a tolR deletion, which
prevents TolQR–TolA complex assembly, to
those of a tolR(D23R) point mutation that allows
complex assembly but prevents TolQR–TolA
from utilizing PMF (Cascales et al., 2001). In
the tolR(D23R) mutant, interaction between TolA
and PBP1B was maintained (Figure 7B), suggest-
ing that physical association between PBP1B-
LpoB and Tol depends on assembly of the
TolQR–TolA complex in vivo but not on its
energy state. In contrast, interaction between
CpoB and LpoB was highly elevated (Figure 7B).
This strongly suggests that TolQR–TolA must be
energized for TolA to prevent CpoB both from
interacting with LpoB and, in conjunction, from
inhibiting PBP1B TPase stimulation by LpoB. This
implies that cycles of TolQR–TolA PMF utilization
and energization can in turn modulate PBP1B
TPase activity, allowing dynamic regulation of
PBP1B activity in response to Tol energy state.
Taken together, interactions between PBP1B-
LpoB, TolA, and CpoB promote physical and
spatial coordination of PBP1B-LpoB and the Tol
apparatus, and provide a mechanism for direct
regulation of septal PG synthesis in response to
Tol function.
Discussion
Despite major progress understanding bacterial
cell division, it has remained unknown how Gram-
negative bacteria coordinate OM invagination
with IM invagination and septal synthesis. In this
work, we present a mechanism for coordinating
PG synthesis and OM constriction, featuring
CpoB, previously of unknown function, as its
centerpiece. The PBP1B-LpoB and Tol machines
Figure 5. PBP1B interacts directly with CpoB and TolA.
(A) CpoB interacts directly with PBP1B in vitro, assayed
by SPR. Sensorgrams show binding of CpoB to a chip
surface with immobilized PBP1B, but not PBP1A or an
Figure 5. continued on next page
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facilitate PG synthesis and OM constriction, re-
spectively, at the closely-spaced leading and
trailing edges of the invaginating envelope
(Figure 1A). We demonstrate that CpoB connects
these processes, promoting physical and func-
tional coordination of the PBP1B-LpoB and Tol
machines. We found that both CpoB and TolA
interact directly with PBP1B, and our in vitro data
support formation of a higher order complex
(Figure 8A). As depicted in our summary model,
interactions between PBP1B, LpoB, CpoB, and
TolA allow for dynamic regulation of PBP1B
activity, and thus functional coordination of the
PBP1B and Tol machines (Figure 8B). Below, we
first discuss how interaction between these ma-
chineries tunes PG synthesis, and then indicate the
physiological importance of this process. We end
with an evolutionary perspective on these findings.
How CpoB tunes PBP1B-LpoB
function to Tol energy state
In the absence of input from CpoB, LpoB binding
to PBP1B stimulates both its GTase and TPase
activities. TPase activation results in hyper-cross-
linked PG (Figure 8B, top left), containing ∼70%
cross-linked peptides in vitro. CpoB binding interferes only with TPase stimulation (Figure 8B, top
right) so that ∼60% of the peptides are cross-linked. Importantly, this level of cross-linking is similar to
that observed in mini-cells, which are formed by abnormal polar divisions in vivo and have an
exclusively polar PG (Obermann and Ho¨ltje, 1994). Therefore, CpoB reduces cross-linkage to a more
physiological level. This may be the default cellular state, as CpoB is present in ∼10-fold excess over
its PBP1B and TolA binding partners (Figure 5—figure supplement 2; Li et al., 2014). CpoB is the
first example of an endogenous regulator that can control the TPase activity of a bifunctional PG
synthase independently of its GTase activity. It thus mimics the activity of penicillin G, which blocks
PBP1B TPase activity without interfering with GTase stimulation by LpoB (Lupoli et al., 2014).
TolA further modulates PBP1B function by reversing CpoB inhibition, in a manner that is
dependent on the state of the Tol apparatus (Figure 8B, bottom panels). Fuelled by PMF-derived
energy, TolQR–TolA cycles between at least two alternative states; we propose that each state has
distinct functional consequences for PG synthesis. During the non-energized phase of Tol function,
CpoB inhibits LpoB-mediated PBP1B TPase hyper-activation (Figure 8B, bottom right). During the
energized phase, however, TolA adopts a new conformation that allows it to alleviate CpoB inhibition,
thereby restoring maximal TPase stimulation by LpoB (Figure 8B, bottom left). Thus, CpoB provides
the means to selectively regulate PBP1B catalytic activities, and TolA modulates this effect, linking
cycles of PBP1B activity state and the resulting PG cross-linking with cycles of TolQR–TolA energy
state while Tol promotes OM invagination.
TolA also directly stimulates PBP1B GTase activity, independently of and additively with LpoB. We
do not yet know whether this stimulation occurs during one or both phases of Tol function.
Importantly, recruitment and assembly of the TolQR–TolA IM sub-complex is required for regulation
of PBP1B by TolA in vivo: in the absence of TolQ or TolR, interaction between TolA and PBP1B is
significantly decreased, whereas interaction between PBP1B and LpoB is enhanced. TolQ and TolA
localize to the septum independently of each other (Gerding et al., 2007), and their recruitment may
incorporate different regulatory cues.
Why is PBP1B tuning necessary for coordinating septal PG synthesis and
OM constriction?
We propose that selectively tuning the GTase and TPase activities of PBP1B offers functional flexibility
that is particularly important during constrictive PG synthesis. PBP1B-LpoB has the capacity to
Figure 5. Continued
empty control surface. Concentrations of trimeric CpoB
(0–0.167 μM) are indicated. (B) The KD of the PBP1B-
CpoB interaction was determined by non-linear
regression using Sigma Plot 11.0, and assuming that
CpoB interacts in its trimeric form. (C) TolA interacts
directly with PBP1B in vitro only when TolA contains its
transmembrane domain I. Interaction between
His6-PBP1B and either full length TolA or TolA(sol),
a soluble variant lacking domain I, was assessed using
an in vitro cross-linking/pull-down approach. His-PBP1B
specifically retained TolA, but not the soluble version
lacking domain I, when pulled down by Ni-NTA beads.
TolA or TolA(sol) alone showed no significant binding to
Ni-NTA.
DOI: 10.7554/eLife.07118.017
The following figure supplements are available
for figure 5:
Figure supplement 1. Demonstration of ternary
complexes in vitro.
DOI: 10.7554/eLife.07118.018
Figure supplement 2. CpoB copy number
determination.
DOI: 10.7554/eLife.07118.019
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produce highly cross-linked PG, which may be required at certain stages of new pole synthesis, but
the TPase activity of PBP1B is normally down-regulated by CpoB. Up-regulation is allowed only during
energized phases of Tol function. Thus, for PBP1B-LpoB at the septal leading edge, increased cross-
linking (TPase) activity is permitted only when the OM is brought into close proximity—as facilitated
by cycles of Tol function and energy utilization—allowing energized TolQR–TolA to counteract CpoB.
The IM-bound septal leading edge can thereby sense and respond the status of the trailing edge of
the constricting envelope (i.e. the OM), and activity cycles of the two machines are synchronized,
helping to ensure a constant distance between the OM and IM. Restricting TPase activity based on Tol
status may also promote better coordination of septal PG synthesis and septal cleavage by OM-
controlled amidases (Uehara et al., 2010; Yang et al., 2011).
By making PBP1B activity responsive to the presence, assembly and energy state of Tol, CpoB
enables potential feedback regulation of PG synthesis based on the status of OM invagination. The
importance of such coordination can be seen when it is broken, as demonstrated by the phenotypes
of a strain lacking CpoB. Multiple antibiotic sensitivities, envelope defects, and genetic interactions
paralleling those of a strain lacking PBP1B suggested that CpoB contributes to proper PBP1B function
in vivo, an interpretation bolstered by the facts that PBP1B overexpression alleviated these ΔcpoB
phenotypes and a strain lacking both proteins phenocopied a PBP1B mutant. Envelope defects in the
absence of CpoB were relatively mild, likely because redundant mechanisms compensate for loss of
coordination by CpoB (e.g., LpoA TPR domain function, discussed below). Yet defects were greatly
exacerbated under osmotic stress (Figure 2—figure supplement 1A) or in the absence of LpoA
function (Figure 2B–F and Figure 2—figure supplement 4B–D), indicating that coordination by
CpoB becomes more crucial under stress and/or when cells must rely more heavily on PBP1B function.
Apparent loss of PBP1B function in the absence of CpoB may result from loss of proper coordination
Figure 6. CpoB modulates stimulation of PBP1B TPase activity by LpoB. GTase and TPase activities of PBP1B in the
presence of LpoB, TolA, and/or CpoB. (A) GTase rate was assayed by consumption of fluorescently labelled lipid II
by PBP1B in vitro. Change in GTase rate is relative to PBP1B alone and is shown as mean ± SD (n = 3–4). (B) TPase
activity was determined by analyzing peptide cross-linkage following in vitro PG synthesis by PBP1B with
radiolabelled lipid II substrate. TPase activity is shown as percentage of peptides present in cross-links in PG
produced by PBP1B (mean ± SD). TPase assays were performed at 150 mM NaCl (n = 4–7) and at an increased salt
concentration of 215 mM NaCl (n = 2, shown as the mean ± maximum and minimum values), at which the negative
impact of CpoB on PBP1B TPase stimulation by LpoB is exacerbated. Statistical significance/difference was
determined by Mann–Whitney U test, with p values of 0.00058 for both data sets.
DOI: 10.7554/eLife.07118.020
The following figure supplement is available for figure 6:
Figure supplement 1. PBP1B GTase and TPase activity assays.
DOI: 10.7554/eLife.07118.021
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with Tol that is required for efficient and productive utilization of PBP1B activity during septation.
In addition, loss of TPase modulation may itself be deleterious, as uncontrolled PG synthase activity
can be as detrimental to the cell as no activity (Cho et al., 2014). Synthetic and hydrolytic enzymatic
reactions have to be carefully balanced for seamless PG growth, a principle exploited by β-lactam
antibiotics, which lyse cells predominantly via uncontrolled PG hydrolase activity (Kohlrausch and
Ho¨ltje, 1991). In this scenario, overexpression of PBP1B may alleviate ΔcpoB phenotypes by ensuring
that there is enough unbound (hypoactive) PBP1B in the cell to counter-balance hyperactive PBP1B-
LpoB in septal PG synthesis.
Coordination of the PBP1B and Tol machines by CpoB may also be important for proper Tol
function. Defects in OM integrity in the absence of PBP1B or CpoB are consistent with such a role.
The molecular mechanism by which Tol facilitates OM constriction remains poorly defined (Gerding
et al., 2007; Egan and Vollmer, 2013), and the energized system is currently not amenable to in vitro
dissection. It is thus more difficult to determine specific regulatory effects of CpoB and PBP1B on Tol
activity. However, coordination likely promotes synchronous OM constriction during cell division, and
reciprocal regulation of Tol activity would allow bidirectional coordination of function. Since PBP1B-
LpoB can partially compensate for loss of Tol (Typas et al., 2010), it is possible that the two
complexes contribute to OM constriction cooperatively. Finally, it is possible that both Tol and CpoB
play additional roles in PG synthesis and/or other envelope processes, which may be elucidated as we
continue to improve our understanding of Tol function in vivo.
Specificity and modularity in PG synthase evolution
PBP1B and PBP1A retain some core functional redundancy, which allows cell survival when only one is
present (Yousif et al., 1985). This partial redundancy adds robustness to cell wall biosynthesis.
However, PBP1B and PBP1A also have distinct roles. PBP1B is adapted to play a key role in cell
division in E. coli, as illustrated by phenotypic, localization, and physical interaction data (Bertsche
et al., 2006; Muller et al., 2007; Typas et al., 2010), and by the fact that cells without PBP1B lyse
Figure 7. Regulatory interactions between CpoB, TolA, and PBP1B-LpoB respond to Tol apparatus assembly and
energy state. (A) and (B). Interactions between CpoB, TolA, PBP1B, and LpoB were characterized in vivo by cross-
linking and co-immunoprecipitation for wild type (WT) and indicated mutant strains. Antibodies specific for CpoB,
TolA, and PBP1B were used to immunoprecipitate their antigens from Triton X-100-solublized E. coli membrane
extracts derived from cells treated with DTSSP cross-linker. Interacting proteins were detected in the immuno-
precipitates by western blot using specific antibodies. IP and input panels are from different blot exposures (see
‘Methods’). (C) Schematic of observed in vivo interactions. Black bars indicate interactions observed in WT; red bars
indicate novel interactions in mutant strains.
DOI: 10.7554/eLife.07118.022
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from the mid-cell at a higher frequency (Garcia del Portillo and de Pedro, 1990). Here, we provide
additional evidence for the specialized role of PBP1B-LpoB complex in cell division, as it interacts and
physically coordinates its function with the Tol apparatus (Gerding et al., 2007). Physical and
regulatory interactions thus link PBP1B to septal PG synthesis (PBP3, FtsN, FtsW; Bertsche et al.,
2006;Muller et al., 2007; Fraipont et al., 2011), PG hydrolysis (MltA; Vollmer et al., 1999), and now
OM constriction (Tol and CpoB), integrating division processes that span the envelope. Multiple
divisome-associated regulators (FtsN, LpoB, CpoB, TolA) either stimulate or inhibit PBP1B activity.
Regulation by other factors may be synergistic or antagonistic with regulation by CpoB and TolA, or
alternatively may be employed at different stages of septation, helping PBP1B to further address
unique requirements of constrictive PG synthesis.
PBPs and other PG-related enzymes (e.g., amidases; Uehara et al., 2009) are often characterized
by modular architecture, combining broadly conserved catalytic domains with evolutionarily confined
non-catalytic domains. We have proposed that these non-catalytic domains provide specificity and
diversification to the enzymes (Typas et al., 2012). In the case of PBP1B, the non-catalytic UB2H
domain shares an extensive binding interface with LpoB (Egan et al., 2014), and as we show here is
also involved in binding CpoB. Interestingly, LpoB and CpoB approach UB2H from different sides
(Figure 8A), consistent with their independent binding to PBP1B. CpoB and LpoB come close in this
conformation, and this proximity could facilitate the LpoB–CpoB interaction, which is stabilized in the
non-energized state of the Tol system. As the UB2H domain and LpoB are present only in
enterobacteria and Vibrionaceae (Typas et al., 2010; Do¨rr et al., 2014), it remains to be determined
Figure 8. Model for physical and functional coordination of the PBPB-LpoB PG synthesis and Tol OM constriction
machines by CpoB. (A) Data-driven docking of the PBP1B/LpoB/CpoB complex calculated with HADDOCK/CNS
protocols (de Vries et al., 2010) and integrating experimental data. The lowest energy structure obtained is shown
with PBP1B, LpoB, and CpoB colored in wheat, pale green, and blue, respectively. LpoB binds the PBP1B UB2H
domain, while CpoB binds in an adjacent cleft between the UB2H and TPase domains (Figure 3). We propose that
CpoB can contact LpoB in this conformation, preventing hyper-activation of the PBP1B TPase by LpoB. TolA
counteracts this CpoB effect, and increases both PBP1B TPase activity (by restoring stimulation by LpoB) and GTase
activity (directly). (B) Schematic of PBP1B regulation by LpoB, CpoB, and TolA. TP: transpeptidase domain; GT:
glycosyltransferase domain. Green circles indicate activity stimulation (increase in glycan synthesis rate for GTase;
formation of more highly cross-linked product for TPase). Top left: LpoB binding stimulates both PBP1B GTase and
TPase activities; the latter produces highly cross-linked PG. Top right: CpoB modulates TPase stimulation without
interfering with GTase stimulation. Bottom left and right: When energized, TolA reverses the effect of CpoB,
restoring production of highly cross-linked PG. Regulation by TolA is thus dependent on TolQR–TolA PMF
utilization, tying cycles of PBP1B TPase activation to cycles of Tol function.
DOI: 10.7554/eLife.07118.023
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whether and how the more conserved Tol system is integrated with septal PG synthesis in other
bacteria. Interestingly, CpoB is not conserved in all bacteria with a Tol system, or even in some that
contain LpoB (e.g., Pasteurellaceae).
We postulate that other niche-specific factors will tightly coordinate PG septal synthesis and
constriction of the different envelope layers in microbes that lack CpoB and/or LpoB. In this regard,
our finding that LpoA has an additional function beyond activating PBP1A, one that is redundant with
(or otherwise exacerbates the need for) CpoB and is independent of PBP1A, is particularly interesting.
First, it extends for the first time the principle of modularity to PG enzyme regulators, as LpoA has two
physically separated domains: one for binding and activating PBP1A (C-terminal domain) and one for
its CpoB-related function (N-terminal TPR domain). Second, as both CpoB and LpoA possess TPR
domains, which are generally involved in protein–protein interactions, it raises the question of whether
both their TPR domains are involved in additional binding and/or regulation with other PG-related
enzymes. Such function(s) could be independent of PBP1A/B binding and regulation. An alternative
scenario, which would explain the CpoB and LpoA redundancy, is that LpoA can directly link to the Tol
system. In contrast to CpoB, we could not detect a direct interaction between LpoA and soluble TolA
in vitro. However, the LpoA connection to TolA may be more complex (e.g., dependent on
conformational state of TolA), or LpoA may achieve a CpoB-like function via connections to other Tol
components. Such a connection would be consistent with the ability of PBP1A to partially substitute
for PBP1B, and with the general role of the Tol system in envelope integrity. As all these components
(PBP1B/A, LpoB/A, CpoB, and Tol) localize independently to division sites, multiple redundant or
alternative paths may exist for coordinating PG synthesis and OM constriction, increasing the
robustness of the process to function under different conditions and across different organisms.
Conclusions
Physical and functional coordination of PBP1B with Tol, facilitated by CpoB, reveals an important
additional layer in the regulatory circuitry that controls PBP1B function, and paints an increasingly
intricate picture of PBP1B as a regulatory scaffold that is uniquely adapted for the coordination of cell
division process in E. coli. This is the first mechanistic view of how different envelope layers talk to each
other as they grow and constrict during cell division in Gram-negative bacteria. Importantly, the process
retains a high degree of modularity, which would allow for individual components to be replaced across
evolution, and presumably to some degree in E. coli itself. Continued dissection of the dynamic, multi-
enzyme, membrane-spanning machines that mediate coordinated cell division processes—including
investigation of which interactions occur simultaneously, when and where in the cell they occur, and what
additional regulatory relationships they confer—will provide greater understanding of the molecular
mechanisms that govern interconnected divisome functions and their synchronization. Looking across
different organisms will also provide a better overview of which interconnections are broadly required
and by what different means they can be achieved. Considering the many facets of cell envelope
composition (Radolf et al., 2012) and cell division (Leisch et al., 2012), these questions are bound to
have different answers in different bacteria. Nevertheless, the geometric and topological changes
inherent during cell division likely generally necessitate a high degree of feedback between the different
envelope layers through physical connections that modulate biochemical activities (Weiss, 2015).
Materials and Methods
Chemicals and proteins
[14C]GlcNAc-labelled lipid II and dansylated lipid II were prepared as published (Breukink et al., 2003;
Bertsche et al., 2005). The following proteins were prepared as previously described: PBP1B
(Bertsche et al., 2006), His-LpoB(sol), and LpoB(sol) (Egan et al., 2014). Antisera against PBP1B,
LpoB, CpoB, TolA, and TolB (rabbit) were obtained from Eurogentec (Liege, Belgium) and purified
over an antigen column as described (Bertsche et al., 2006). Cellosyl was provided by Hoechst AG
(Frankfurt, Germany). VIM-4 was a kind gift from Adeline Derouaux.
Protein overproduction and purification
BL21(DE3) strains harbouring plasmids pET28-His6-CpoB (for the purification of CpoB; signal
sequence replaced by a cleavable oligohistidine tag), pET28-TolA-His6 (for the purification of full
length TolA with a C-terminal oligohistidine tag), pET28-His6-TolA (for the purification of full length
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TolA with a cleavable N-terminal oligohistidine tag) or pET28-His6-TolA(sol) (for purification of TolA
(72-421)) were grown in 3 L of LB medium with appropriate supplements at 30˚C to an OD578 of
0.5–0.6. Recombinant genes were overexpressed by adding 1 mM IPTG to the cell culture followed by
a further incubation for 3 hr at 30˚C. Cells were harvested by centrifugation (10,000×g, 15 min, 4˚C)
and the pellet was resuspended in buffer I (25 mM Tris/HCl, 10 mM MgCl2, 500 mM NaCl, 20 mM
imidazole, 10% glycerol, pH 7.5). A small amount of DNase, protease inhibitor cocktail (Sigma-
Aldrich, St. Louis, MO; 1/1000 dilution), and 100 μM phenylmethylsulfonylfluoride (PMSF) were
added before cells were disrupted by sonication (Branson digital). The lysate was centrifuged
(130,000×g, 1 hr, 4˚C). At this point, purification procedures of full length TolA constructs and of
CpoB and TolA(sol) differ.
For CpoB and TolA(sol), the supernatant was applied to a 5-mL HisTrap HP column (GE healthcare
Bio-Sciences, Piscataway, NJ), attached to an A¨KTA Prime+ (GE Healthcare Bio-Sciences) at 1 mL/min.
The column was washed with 4 volumes buffer I before step-wise elution of bound proteins with buffer
II (25 mM Tris/HCl, 10 mM MgCl2, 500 mM NaCl, 400 mM imidazole, 10% glycerol, pH 7.5). To
remove the oligohistidine tag from His-CpoB and His-TolA(sol), 50 U/mL of restriction grade thrombin
(Merck Millipore, Darmstadt, Germany) was added, and the protein was then dialyzed against 2 L of
25 mM Tris/HCl, 10 mM MgCl2, 500 mM NaCl, 10% glycerol, pH 7.5 for 18 hr at 4˚C. Proteins samples
were then concentrated to 4–5 mL using a VivaSpin-6 column (MW cut-off 6000 Da) and applied to
a Superdex200 HiLoad 16/600 column at 0.8 mL/min for size exclusion chromatography in 25 mM Tris/
HCl, 1 M NaCl, 10% glycerol, pH 7.5. Finally, proteins were dialyzed against storage buffer (25 mM
Tris/HCl, 500 mM NaCl, 10% glycerol, pH 7.5).
For full length TolA or TolA-His, the membrane pellet resulting from the above ultracentrifu-
gation was resuspended in extraction buffer (25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, 2% Triton
X-100, 10% glycerol, pH 7.5) and incubated overnight with mixing at 4˚C. Samples were centrifuged
(130,000×g, 1 hr, 4˚C) and the supernatant applied to a 5-mL HisTrap HP column (GE Healthcare
Bio-Sciences) attached to an A¨KTA Prime+ (GE Healthcare Bio-Sciences) at 1 mL/min. The column
was washed with 4 volumes extraction buffer, followed by 4 volumes of wash buffer I (25 mM Tris/
HCl, 10 mM MgCl2, 1 M NaCl, 20 mM imidazole, 2% Triton X-100, 10% glycerol, pH 7.5), followed
by a final wash with 4 volumes of wash buffer II (as wash buffer I, with 40 mM imidazole and 0.2%
Triton X-100). Bound protein was eluted step-wise with elution buffer (25 mM Tris/HCl, 10 mM
MgCl2, 500 mM NaCl, 400 mM imidazole, 0.2% Triton X-100, 10% glycerol, pH 7.5). At this point,
TolA-His was dialyzed into storage buffer (25 mM Tris/HCl, 500 mM NaCl, 0.2% Triton X-100, 10%
glycerol, pH 7.5). To remove the oligohistidine tag from His-TolA, 50 U/mL of restriction grade
thrombin (Merck Millipore) was added to the protein, which was then dialyzed against 2 L of 25 mM
HEPES/NaOH, 10 mM MgCl2, 50 mM NaCl, 10% glycerol, pH 6.0 for 24 hr at 4˚C. Sample was then
applied to a 5-mL HiTrap HP SP column attached to an A¨KTA Prime+ (GE Healthcare Bio-Sciences)
for ion exchange chromatography, at a flow rate of 0.5 mL/min in buffer A (25 mM HEPES/NaOH,
10 mM MgCl2, 50 mM NaCl, 0.2% Triton X-100, 10% glycerol, pH 6.0). The column was washed with
6 volumes buffer A before stepwise elution of bound TolA with buffer B (as A, with 500 mM NaCl).
TolA sample was then dialyzed into storage buffer (25 mM HEPES/NaOH, 10 mM MgCl2, 100 mM
NaCl, 0.2% Triton X-100, 10% glycerol, pH 7.5). Recombinant PBP1B (pDML924; the functional,
short PBP1Bγ version, starting from amino acid 46) was purified as described previously (Bertsche
et al., 2005). Versions of proteins retaining their His-tags were purified as above, omitting the
addition of thrombin.
Bacterial strains, plasmids, and growth conditions
Bacterial strains and plasmids used in this work are listed in Supplementary File 1A. Primers used in
this work are listed in Supplementary File 1B.
Growth conditions
For in vivo assays, cells were grown aerobically at 30˚C or 37˚C in Lennox Luria–Bertani (LB) medium
(10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl) (Fisher Scientific, Houston, TX) unless otherwise
indicated. Where appropriate, antibiotics or inducers were added: ampicillin (100 μg/mL), chloramphen-
icol (10–34 μg/mL), kanamycin (30 μg/mL), arabinose (0.2–1%, wt/vol), IPTG (1 mM). For protein
production, cells were grown aerobically at 30˚C or 37˚C in Miller LB medium (10 g/L tryptone, 5 g/L yeast
extract, 10 g/L NaCl).
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Construction of E. coli strains
To generate and combine E. coli gene deletions, kan-marked alleles from the Keio E. coli single-gene
knockout library (Baba et al., 2006) were transferred into relevant background strains using P1 phage
transduction (Thomason et al., 2007). The Keio pKD13-derived kan cassette is flanked by FRT sites,
allowing removal of the kan marker via expression of FLP recombinase to generate unmarked
(kanamycin-sensitive) deletions with a FRT-site scar sequence (Datsenko and Wanner, 2000; Baba
et al., 2006).
Other chromosomal mutations and gene fusions (lpoA(Δ58-252), tolQ(D23R), cpoB-mCherry, and
gfpmut2-tolA) were generated via lambda Red recombinase-mediated oligonucleotide and/or PCR
recombineering (Thomason et al., 2014) using recombineering plasmid pSIM19 (Datta et al., 2006).
Desired mutations were confirmed by PCR and sequencing. To generate the lpoA(Δ58-252) strain,
a sacB-kan cassette from pIB279 (Blomfield et al., 1991) was amplified using primers ANG014 x
ANG015 and inserted into lpoA to generate precursor strain CAG70134 (BW25113 lpoA(Δ1-255::
(sacB-kan)). A PCR product containing the lpoA(Δ58-252) allele was then generated via overlap
extension (‘stitching’) PCR (Heckman and Pease, 2007), using PCR primers ANG235 x ANG239 and
ANG241 x ANG242 with E. coli genomic DNA as template for the first round of PCR and ANG235 x
ANG242 with first-round-PCR-products as template for the second round of PCR. The PCR product
was then used to replace the sacB-kan cassette via counterselection on no-salt LB plates (10 g/L
tryptone, 5 g/L yeast extract, 18 g/L agar) containing 7% (wt/vol) sucrose. To generate the tolQ
(D23R) strain, a sacB-cat cassette from plasmid pDS132 (Philippe et al., 2004) was amplified using
primers ANG478 x ANG479 and inserted into tolQ to generate strain CAG70764 (BW25113 tolR
(D23::(sacB-cat)). The tolQ(D23R) mutation was then introduced by using oligonucleotide ANG484 to
replace the sacB-cat cassette via sucrose counterselection. To generate the cpoB-mCherry strain,
sacB-cat was inserted after cpoB using primers ANG143 x ANG144 and replaced with a GSGSGSGS
linker followed by mCherry using primers ANG177 x ANG178 with pMG36 (encodes pal-mCherry)
(Gerding et al., 2007) as template. To generate the gfpmut2-tolA strain, sacB-cat was inserted
before tolA using primers ANG263 x ANG264 and replaced with gfpmut2 followed by an ATGTRT
linker using primers ANG347 x ANG349 with pBAD24-gfp (Nilsen et al., 2004) (encodes gfpmut2) as
template.
To transfer chromosomal mutations and gene fusions to other strain backgrounds, the sacB-cat or
sacB-kan cassette was first transferred to the intended recipient strain by P1 phage transduction
(Thomason et al., 2007). The unmarked mutant allele was then transferred into the sacB-cat or sacB-
kan-bearing recipient strain by P1 phage transduction with selection on no-salt LB plates containing
7% (wt/vol) sucrose and 10 mM potassium citrate. (Potassium citrate is substituted for sodium citrate
because the addition of sodium prevents sacB-mediated sucrose sensitivity.)
Construction of plasmids
pBAD33-PBP1B was constructed by cloning mrcB (encodes PBP1B) along with 20 bp of upstream
sequence so as to include the native ribosome binding site (PCR primers: ANG093 x ANG094) into
the SacI/XbaI restriction sites of pBAD33 (Guzman et al., 1995). Similarly, pBAD33-CpoB was
constructed by cloning cpoB with 25 bp upstream sequence into SacI/SphI pBAD33 (PCR primers:
ANG005 x ANG006). Similarly, pTolA (pBAD33-TolA) was constructed by cloning tolA with 20 bp
upstream sequence into SacI/XbaI pBAD33 (PCR primers: ANG147 x ANG148). For pET28-His6-
CpoB, cpoB was cloned into NdeI/SacI pET28a (EMD Millipore, Billerica, MA) (PCR primers:
ANG182 x ANG184). For pET28-His6-TolA, tolA was cloned into NdeI/SacI pET28a, replacing the
native GTG tolA start codon with the NdeI site ATG. For pET28-His6-TolA(sol), tolA(74-421) was
cloned into NdeI/SacI pET28a. For pET28-TolA-His6, tolA (without stop codon) was cloned into
NcoI/XhoI. The forward primer used to amplify tolA contained a BsaI restriction site,
GGTCTCTCATG, to allow cloning into the pET28 NcoI site while preserving the native tolA
sequence after the start codon.
Amber (TAG) mutations were introduced in pDML924 using the QuickChange PCR site-directed
mutagenesis kit and protocol (Stratagene/Agilent Technologies, Santa Clara, CA). PCR reactions were
treated with DpnI (Fermentas/Thermo Fisher Scientific, Waltham, MA) to remove parent plasmid and
then transformed into E. coli DH5α. Candidate plasmid derivatives containing amber mutations were
purified from isolated transformants and confirmed by sequencing.
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Growth fitness assays (related to Figure 2, Figure 2—figure
supplements 2–4, and Figure 4—figure supplement 1)
E. coli gene deletion alleles were derived from the Keio collection (Baba et al., 2006). Strains for
overexpressing PBP1B carried arabinose-inducible plasmid pBAD33-PBP1B. Strains for expressing
YbgF in trans (for complementation of ΔcpoB) carried arabinose-inducible plasmid pBAD33-CpoB.
E. coli wild type and mutant strains were arrayed and grown in a 1536-colony format (n ≥ 96 for each
strain) on LB Lennox plates (20 g/L agar) at 37˚C, then replica-pinned robotically (Rotor HDA, Singer
Instruments, Roadwater, UK) to LB Lennox and/or indicated condition plates. Assay plates were
incubated for 8–14 hr at 37˚C and then imaged. Colony sizes were determined using in-house software.
Analysis of periplasmic leakage and OM blebbing (related to Figure 2
and Figure 2—figure supplement 4)
Imaging
For DIC and fluorescence imaging for example images (Figure 2C), cells were imaged at the Nikon
Imaging Center (NIC) at UCSF on a Ti-E Microscope with a Plan Apo VC 100×/1.4 Oil (DIC N2 / 100X I)
65.4 nm/pixel objective. Images were collected using a Nikon Coolsnap HQ2 camera and NIS-
Elements v4.2 software (Nikon Instruments Inc., Melville, NY). For phase-contrast and fluorescence
imaging for quantitation (Figure 2D,E and Figure 2—figure supplement 4B,C), cells were imaged on
a Nikon Eclipse TE inverted fluorescence microscope with a 100× (NA 1.40) oil-immersion objective.
Images were collected using an Andor DC152Q sCMOS camera (Andor Technology, South Windsor,
CT) and MicroManager v1.3 software (Edelstein et al., 2010).
Quantitation of periplasmic leakage and OM blebbing
Strains were grown in LB Lennox broth with 1 mM ITPG to induce periplasmic mCherry expression. 1%
arabinose and 10 μg/mL chloramphenicol were added for plasmid-bearing strains. Overnight cultures
were diluted 1:200 and then grown in a 96-well microplate (Model #780271; Greiner Bio-One, Monroe,
NC) for 2 hr before imaging. Phase-contrast images were segmented using a custom MATLAB software
package called Morphometrics, as in Ursell et al. (2014). The software is currently in beta version and
freely available upon request (kchuang@stanford.edu); the release version will be made available on
Bitbucket. Related scripts for measurement of periplasmic leakage (peripheral fluorescence) and outer
membrane blebs/vesicles (fluorescent puncta) are also available from Bitbucket in the kchuanglab/
Gray_eLife_CpoB repository. To measure fluorescence profiles along cell outlines, fluorescence intensity
was measured along segmented cell contours with a spacing of 1 pixel (0.064 μm). Cells were defined as
exhibiting periplasmic leakage if their median contour fluorescence fell below a threshold defined as the
98th percentile of ΔtolA cell contour fluorescence. To identify blebs, we first located all fluorescent
puncta with average brightness above the 99.7th percentile of WT cell brightness, and with an area
smaller than 4 μm2. Blebs were then defined as isolated bright puncta within 0.3 μm of a segmented cell.
Chlorophenyl red-β-D-galactopyranoside (CPRG) penetration assay
(related to Figure 2—figure supplement 1A,B)
The CPRG assay was performed as described (Paradis-Bleau et al., 2014) with slight modifications.
Instead of normal rectangular agar plates in which colonies are arrayed next to each other and color
can diffuse, we used 384-well plates, filled with LB-agar-CPRG by a liquid handling robot (Biomek FX;
Beckman Coulter, Brea, CA). Mutants carrying pCB112, a mobile plasmid encoding lacZ under control
of the lactose promoter (Plac), were arrayed robotically on each well (ROTOR, Singer Instruments).
Color development (CPR-red; 570 nm) was monitored for 48 hr (every 30 min) in a multi-well plate
reader (Tecan M1000 Pro with a stacker) at room temperature. Absorption wavelength (not to overlap
with colony development), agar volume per well and a number of other technical parameters were
optimized for the assay (George Kritikos and Athanasios Typas; unpublished data). The accumulation
rate of CPR color was calculated after fitting a linear curve on an absorption-time plot.
Filtered culture supernatants (related to Figure 2—figure
supplement 1C)
Culture supernatants were collected and filtered using a 0.2 μm-pore SFCA syringe filter (Fisher
Scientific), then TCA-precipitated and prepared for analysis by SDS-PAGE and western blot as
described (Wagner et al., 2009).
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In vivo pBpa cross-linking experiments (related to Figure 3)
Amber mutations were introduced at indicated sites via site-directed mutagenesis of plasmid
pDML924, which encodes His6-tagged PBP1B (Terrak et al., 1999). E. coli BL21(DE3) cells were co-
transformed with pSup-BpaRS-6TRN (Ryu and Schultz, 2006) and either pDML924 or amber mutant
derivatives. Cells were grown to an OD600 of 0.5–0.6; protein production was then induced with 10 μM
IPTG, and 1 mM freshly-prepared p-benzoyl-L-phenylalanine (Bachem) dissolved in 1 M NaOH was
added. After 2 hr of protein production, cells were harvested by centrifugation, washed with PBS and
resuspended in 3 mL PBS, then transferred to a petri dish and exposed to UV light (365 nm) for 1.5 min
(photoMax Housing 200W, model 60100, 30 cm distance to sample; Oriel Instruments). Cells were
cooled on ice during UV illumination. Cell samples were separated by SDS-PAGE (8%), transferred to
a nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA), and analyzed by western blot using
monoclonal anti-polyhistidine peroxidase-conjugated antibody (1:4000 dilution; Sigma-Aldrich).
Mass spectrometry and related data analysis (related to Figure 3 and
Table 1)
Excised protein bands were reduced with DTT, alkylated with iodoacetamide and in-gel digested with
trypsin (Shevchenko et al., 2006). Nanoflow liquid chromatography coupled to mass spectrometry
was performed on an Agilent 1200 nanoflow system (Agilent Technologies) connected to a MS LTQ-
Orbitrap XL (Thermo Fisher Scientific). The samples were trapped on a 20 mm ReproSil-Pur C18-AQ
(Dr. Maisch GmbH, Ammerbuch, Germany) trapping column (packed in-house, i.d., 100 μm; resin, 5
μm) with a flow-rate of 5 μL/min. Sequential elution of peptides was accomplished using an analytical
column (Dr. Maisch GmbH; packed in-house, i.d., 50 μm; resin, 3 μm) with a 35 min gradient of
10–38% buffer B (buffer A, 0.1 M acetic acid; buffer B, 0.1 M acetic acid, 80% [vol/vol] acetonitrile)
followed by 38–100% B in 3 min, 100% B for 2 min. The flow rate was passively split from 0.45 mL/min
to 100 nL/min (Nesvizhskii et al., 2003). Nanospray was achieved using a distally coated fused silica
emitter (made in-house, o.d., 375 μm; i.d., 20 μm) biased to 1.7 kV. Mass spectrometer was operated
in the data dependent mode to automatically switch between MS and MS/MS. The high resolution
survey full scan was acquired in the orbitrap from m/z 350 to m/z 1500 with a resolution of 30.000
(FHMW). The most intense ions at a threshold of above 500 were fragmented in the linear ion trap
using collision-induced dissociation at a target value of 10,000.
Peak lists were generated from the raw data files using the Proteome Discoverer software package
version 1.3.339 (Thermo Fisher Scientific). Peptide identification was performed by searching the
individual peak lists against a concatenated target-decoy database containing the E. coli sequences in
the Uniprot database (release 2012_06) supplemented with a common contaminants database using
the Mascot search engine version 2.3 (Matrix Science, London, United Kingdom) via the Proteome
Discoverer interface. The search parameters included the use of trypsin as proteolytic enzyme
allowing up to a maximum of two missed cleavages. Carbamidomethylation of cysteines was set as
a fixed modification, whereas oxidation of methionines was set as a variable modification. Precursor
mass tolerance was initially set at 50 ppm, while fragment mass tolerance was set at 0.6 Da.
Subsequently, the peptide identifications were filtered for an ion score of 20.
Fluorescence localization, immunolocalization, and related image
analysis (related to Figure 4 and Figure 4—figure supplements 2–5)
Cells were grown to steady state in glucose minimal medium (GB1) pH 7.0 (den Blaauwen et al.,
1999) supplemented with 50 μg/mL of required amino acids (LMC500 and derived strains) or 20 μg/
mL thymine (BW25113 and derived strains) at 28˚C, or in Lennox LB medium pH 7.0 at 28˚C, as
indicated. Absorbance was measured at 450 nm (GB1) or 600 nm (Lennox LB) with a Biochrom Libra
S70. Generation times of the LMC500 strain grown in GB1 and Lennox LB medium at 28˚C are 85 and
40 min, respectively, and for BW25113 are 92 and 40 min, respectively.
Fluorescence localization of CpoB-mCherry and GFPmut2-TolA
mCherry was placed in frame after the endogenous cpoB gene in the chromosome of E. coli MC4100
(LMC500); gfpmut2 was placed in frame before the tolA gene (see ‘Bacterial strains and plasmids’,
above). Cells were grown to steady state in glucose minimal medium at 28˚C, then placed on a 0.5 ×
0.5 cm 1% agarose patch (Koppelman et al., 2004) containing minimal medium on an object
glass to allow for optimal aeration, covered by a cover glass and immediately imaged as described
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(van der Ploeg et al., 2013). Images were acquired with Micro-Manager (http://www.micro-manager.
org/) with direct output of the desired hyperstack structure for ImageJ by Wayne Rasband (http://
imagej.nih.gov/ij/). CpoB-mcherry was used because the localization of freely diffusing periplasmic
proteins was observed to be perturbed by fixation of cells grown in minimal medium, likely due to
osmotic effects. GFP-TolA was used because available antiserum was not useable for immunolabeling.
Both fusions were functional (Figure 4—figure supplement 1).
Immunolocalization
E. coli cells of wild type strain LMC500 were grown to steady state in glucose minimal medium at 28˚C,
then fixed while shaking in growth medium as described (den Blaauwen et al., 2003). Cells were
permeabilized and immunolabelled with indicated antibodies as described (den Blaauwen et al.,
2003), immobilized on 1% agarose and imaged as above. Bodipy-12, a membrane binding dye, was
used as a control to show at what stage constriction results in increased mid-cell fluorescence due to
the presence of two membranes. Antisera against PBP1B and LpoB were affinity purified and pre-
incubated with cells of their respective deletion strains before use in immunolabeling. Antisera against
FtsZ and FtsN were specific without further purification. The immunolabeling method used here has
been shown to be reproducible and to not perturb the localization of membrane and cytoplasmic
proteins (van der Ploeg et al., 2013).
Related image analysis
Image analysis was performed as described (van der Ploeg et al., 2013). Briefly, individual
cells were identified and analyzed using the public domain program Coli-Inspector, running
under plugin ObjectJ written by Norbert Vischer (University of Amsterdam, https://sils.fnwi.
uva.nl/bcb/objectj/), which runs in combination with ImageJ. Via this analysis, parameters
including cell length, cell diameter (width) as a function of length, and integrated fluorescence
as a function of length (fluorescence profile) were quantified for each cell. For each examined
protein, fluorescence profiles of 3000–5000 individual cells were sorted according to cell
length to generate profile maps (Figure 4B), similar to demographs (Hocking et al., 2012).
A cell diameter profile map (Figure 4B, bottom panel) was generated from imaged cells that
were fixed only. Percentage of cell cycle progression (age) for individual cells was determined
based on relative cell length ranking, assuming a logarithmic growth of cell length (Aarsman
et al., 2005). Average fluorescence profiles for either all cells or specific age ranges were
generated and plotted against normalized cell length as described (Potluri et al., 2010;
Figure 4C). Cell ages corresponding to the initiation of mid-cell localization and peak mid-cell
localization for each examined protein (Figure 4D) were determined as described in
Figure 4—figure supplement 3 and below.
CpoB immunolocalization and related image analysis (related
to Figure 4—figure supplements 2, 4, and 5)
To examine cell division protein dependencies for CpoB mid-cell localization (Figure 4—figure
supplement 4), isogenic strains based on the parental strain LMC500 (see ‘Bacterial strains and
plasmids’, above) with temperature-sensitive alleles of cell division proteins (Taschner et al.,
1988) were used. Cells were grown in glucose minimal medium at 28˚C (permissive temperature)
to an OD450 of 0.2. Subsequently, the growing cells were diluted 1:4 into pre-warmed medium
(28˚C or 42˚C) and grown until the cultures again reached an OD450 of 0.2. Cells were fixed,
permeabilized, and immunolabeled as described (‘Methods’ and den Blaauwen et al., 2003)
using antibody to CpoB that had been pre-adsorbed on permeabilized ΔcpoB cells to remove
cross-reacting antibodies, as described previously (Buddelmeijer et al., 2013). Cells were sorted
according to length to generate fluorescence profile maps, as described in ‘Methods’ (∼500–1000
cells per profile). The FtsZ(ts) strain LMC509 (Taschner et al., 1988) is not completely
temperature sensitive; consequently, CpoB still localizes at mid-cell in shorter cells in this strain;
however, in long smooth cells, no mid-cell localization is seen. The PBP3(ts) strain LMC510
(Taschner et al., 1988) is already somewhat elongated at the permissive temperature due to the
presence of an unstable PBP3 molecule (Fraipont et al., 2011). The FtsW(ts) strain JLB17 is not
isogenic to LMC500 (Ishino et al., 1989; Mohammadi et al., 2014) and was grown in Lennox LB
medium without salt and with 1% glucose and 20 mg/mL of thymine at 28˚C to an OD600 of 0.3.
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 21 of 29
Research article Microbiology and infectious disease
Strain JOE565 (FtsN depletion) (Chen and Beckwith, 2001) was grown in Lennox LB with 0.2%
arabinose at 28˚C to an OD600 of 0.3. Cells were washed in warm medium without arabinose and
resuspended in medium without arabinose to deplete FtsN. For aztreonam treatment (inhibits
PBP3), LMC500 was grown in glucose minimal medium at 28˚C to an OD450 of 0.2. The culture was
then split and diluted 1:4 into medium with or without 2 μg/mL aztreonam and grown for an
additional two mass doublings.
To examine dependency on PBP1B or TolA for CpoB mid-cell localization (Figure 4—figure
supplement 5), wild type strain BW25113 and isogenic derivatives lacking mrcB or tolA were used.
Cells were grown in Lennox LB medium at 28˚C to an OD600 of 0.3, diluted 1:25 into pre-warmed
medium and grown until the cultures again reached an OD600 of 0.3, then fixed, immunolabeled with
antibody to CpoB and imaged as described above. Cells were sorted according to length to generate
fluorescence profile maps, as described in ‘Methods’ (∼1500 cells per profile). The ΔtolA strain had
increased CpoB immunofluorescence levels, with accumulation at constriction sites (Figure 4—figure
supplement 5B, middle two panels); TolA overexpression (pTolA; see ‘Bacterial strains and plasmids’)
alleviated this effect and reduced CpoB immunofluorescence levels to below that of wild type
(Figure 4—figure supplement 5B, right two panels).
Initiation and peak fluorescence localization (related to Figure 4—figure
supplement 3)
Age of localization initiation was defined as the age class when extra mid-cell fluorescence was first
observed, as shown and described in Figure 4—figure supplement 3A. Age of peak localization was
defined as the Moment (Figure 4—figure supplement 3B), i.e. the age when extra mid-cell fluorescence
reached its maximum. For each analyzed cell image, extra mid-cell fluorescence was calculated as ‘FCplus’
and plotted vs cell age to determine the Moment, as described (van der Ploeg et al., 2013).
In vitro protein interaction and activity assays (related to Figure 5,
Figure 5—figure supplement 1, Figure 6 and Figure 6—figure
supplement 1)
SPR experiments were performed as previously described (Egan et al., 2014). The concentration of
CpoB injected ranged from 0.05 to 0.5 μM, or 0.017–0.167 μM assuming trimerization. Assays were
performed in triplicate at 25˚C, at a flow rate of 75 μL/min and with an injection time of 5 min. The
dissociation constant (KD) was calculated by non-linear regression using SigmaPlot 11 software (Systat
Software Inc.). Continuous fluorescence GTase assays and measurement of TPase activity using
radiolabelled lipid II substrate were performed as described previously (Bertsche et al., 2005;
Banzhaf et al., 2012) with slight modification. Triton X-100 concentration varied, depending on
constituent proteins, from 0.04 to 0.075%. Fold-increases in GTase rates were calculated against the
mean rate obtained with PBP1B alone at the same reaction conditions, at the fastest rate.
In vitro cross-linking—pulldown and non-reversed immunoblot
approaches
Proteins were mixed at appropriate concentrations in 200 μL of binding buffer (10 mM HEPES/
NaOH, 10 mM MgCl2, 150 mM NaCl, 0.05–0.09 % Triton X-100, pH 7.5). PBP1B or His-PBP1B at
1 μM was used, with 2 μM LpoB(sol) or His-LpoB(sol), 1 μM TolA or TolA-His and 4 μM CpoB or
His-CpoB where indicated. Samples were incubated at room temperature for 10 min before
addition of 0.2% wt/vol formaldehyde (Sigma-Aldrich) and further incubation at 37˚C for 10 min.
Excess cross-linking was blocked by addition of 100 mM Tris/HCl, pH 7.5. At this point the two
approaches diverge. For the pulldown approach, samples were applied to 100 μL of washed and
equilibrated Ni-NTA superflow beads (QIAGEN, Hilden, Germany) and incubated overnight at
4˚C, with mixing. Beads were then washed with 6 × 1.5 mL wash buffer (10 mM HEPES/NaOH,
10 mM MgCl2, 500 mM NaCl, 50 mM imidazole, 0.05% Triton X-100, pH 7.5). Retained proteins
were eluted by directly boiling beads in SDS-PAGE loading buffer; beads were then removed, and
samples resolved by SDS-PAGE. Gels were stained with Coomassie brilliant blue (Roth, Germany).
For the non-reversed immunoblot approach, samples were resolved by non-denaturing 4–20%
gradient SDS-PAGE and transferred to nitrocellulose membrane by western blot. Proteins
were identified using specific antibodies; detection was with ECL prime chemiluminescence
(GE Healthcare Bio-Sciences) imaged using an ImageQuant LAS4000mini (GE Healthcare Bio-
Sciences).
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In vivo DTSSP cross-linking and co-immunoprecipitation assays (related
to Figure 7)
Assays were performed as described (Bertsche et al., 2006; Typas et al., 2010) with minor
modifications: Cells were grown overnight, diluted 1:400 into 250 mL Lennox LB, and grown with
shaking in baffled flasks at 30˚C to OD600 = 0.3–0.4. Cells were then pelleted by centrifugation and
resuspended at density of ∼1010 cells/mL (i.e., equivalent to OD600 = 10) in 8.0-mL ice-cold CL Buffer I
(50 mMNaH2PO4 20% [wt/vol] sucrose pH 7.4) with 100 μg/mL DTSSP (freshly prepared as a 20 mg/mL
stock in CL Buffer I). Cells were incubated at 4˚C with mixing for 1 hr, then pelleted and frozen at
−80˚C. Cells were then thawed, resuspended at OD600 = 4 in ice-cold CL Buffer II (100 mM Tris–HCl
10 mM MgCl2, 1 M NaCl pH 7.5) with 100 μM PMSF, 50 μg/mL protease inhibitor cocktail (P8465,
Sigma-Aldrich) and 50 μg/mL DNAse I, and lysed using a microfluidizer. Otherwise, method was as
described in (Bertsche et al., 2006; Typas et al., 2010). Antibody amounts for immunoprecipitation
were optimized to capture all detectible target protein, as assessed by western blot of pellet and
supernatant fractions. Pelleted material was extracted in 1/10 original volume SDS-PAGE buffer to
concentrate the final IP fraction.
Data-driven structural docking models (related to Figure 8A)
The docking models of CpoB/PBP1B/LpoB complex were built using HADDOCK2.1 data-driven
docking protocols (Dominguez et al., 2003) and CNS1.2 (Brunger et al., 1998) for the structure
calculations. The initial coordinates of the CpoB, PBP1B, and LpoB molecules were taken from the
PBP1B crystal structure (PDB code 3VMA) (Sung et al., 2009), the CpoB crystal structure from the
N-terminal domain (2XDJ) and the C-terminal TPR domain (2XEV) (Krachler et al., 2010), and from
the LpoB NMR structure (2MII) (Egan et al., 2014). During the multi-body docking, ambiguous
restraints were applied to drive the docking according to the different experimental data.
For LpoB, ambiguous interaction restraints were defined based on the NMR chemical shift
perturbation mapping recorded on the LpoB/UB2H complex and on the in vivo and in vitro
activities of LpoB and PBP1B alleles as described in Egan et al. (2014). For CpoB, in vivo cross-
linking detected using pBpa substitutions at PBP1B residues 118, 123, 751, and 753 were used as
active restraints to drive the interaction between PBP1B and CpoB. Due to the absence of a unique
structure of the disordered N-terminal domain of LpoB (residues 1–60) and the linker between the
N- and C-terminal domains of CpoB (residues 91–108), the two regions were treated as fully
flexible.
The docking was performed with default HADDOCK parameters including a clustering cutoff of
7.5 A˚. The HADDOCK score was used to rank the generated models (Lutje Hulsik et al., 2013). The
generated docking models were analyzed within the Pymol software.
Determination of CpoB copy number (related to Figure 5—figure
supplement 2)
BW25113 and BW25113 ΔcpoB were grown in 50 mL of LB to an OD578 of 0.3. The culture was
then back-diluted 1:50 into 50 mL fresh LB and grown to an OD578 of 0.3. Cells were then cooled
on ice for 10 min prior to harvesting 5 mL by centrifugation (10,000×g, 10 min, 4˚C). At this point,
a viable count was also performed to determine the number of cells per milliliter of culture (see
below). The pellets were resuspended in 100 μL TBS (Tris-buffered saline) buffer and lysed by
addition of 100 μL SDS-PAGE loading buffer and boiling for 10 min. 3 × 20 μL samples of
BW25113 lysate were resolved by SDS-PAGE along with purified CpoB standards (0, 1, 2, 4, 8, and
16 ng) loaded in 20 μL of BW25113 ΔcpoB lysate. CpoB was detected with specific antibody after
western blot (Figure 5—figure supplement 2). Images were analyzed using ImageQuant
LAS4000 software, giving the chemiluminescence signal derived from CpoB bands over the
background (the signal at the same position as CpoB in the 0 ng sample was used as the
background). A standard curve was plotted using the known CpoB standards and the amount of
CpoB in the BW25113 lysate samples was calculated. This was then converted to molecules per
cell using the viable counts, which were performed as follows: Cells were serially diluted 10-fold
in ice-cold LB. 100 μL of the 10−5 and 10−6 dilutions were plated on LB agar and grown overnight
at 37˚C; colonies were then counted and the number of cells per milliliter of culture was
calculated.
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 23 of 29
Research article Microbiology and infectious disease
Acknowledgements
We thank Adeline Derouaux and Tom Bernhardt for reagents and strains. We thank Monica Guo and
Jason Peters for critical reading of the manuscript.
Additional information
Funding
Funder Grant reference Author
Wellcome Trust 101824/Z/13/Z Waldemar Vollmer
National Institutes of Health
(NIH)
5RO1GM102790 Carol A Gross
National Institutes of Health
(NIH)
1P50GM107615-01 Kerwyn Casey
Huang
Alexander von Humboldt-
Stiftung
Sofja Kovalevskaja Award Athanasios Typas
European Molecular Biology
Laboratory
internal funding Athanasios Typas
European Commission DIVINOCELL project FP7-
Health-2007-B-223431
Tanneke den
Blaauwen
Nederlandse Organisatie voor
Wetenschappelijk Onderzoek
Council for Chemical Sciences
ECHO project # 700.59.005
Eefjan Breukink
National Science Foundation
(NSF)
CAREER Award
MCB-1149328
Kerwyn Casey
Huang
Stanford University Graduate Fellowship Alexandre Colavin
Netherlands Organisation for
Scientific Research
Proteins At Work, National
Roadmap Large-scale Research
Facilities of the Netherlands,
Project number 184.032.201
A F Maarten Altelaar
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
ANG, AJFE, Conception and design, Acquisition of data, Analysis and interpretation of data,
Drafting or revising the article; IL’V, AC, Acquisition of data, Analysis and interpretation of data,
Drafting or revising the article; JV, AK, JB, AFMA, MJD, Acquisition of data, Analysis and
interpretation of data; KCH, J-PS, Analysis and interpretation of data, Drafting or revising the article;
EB, TB, AT, CAG, WV, Conception and design, Analysis and interpretation of data, Drafting or
revising the article
Author ORCIDs
Alexandra Koumoutsi, http://orcid.org/0000-0001-8368-4193
Additional files
Supplementary file
·Supplementary File 1. Bacterial strains and plasmids used in this study.
DOI: 10.7554/eLife.07118.024
Major datasets
The following previously published datasets were used:
Author(s) Year Dataset title
Dataset ID
and/or URL
Database, license, and
accessibility information
Sung MT, Lai YT, Huang
CY, Chou LY, Shih HW,
Cheng WC, Wong CH,
Ma C
2009 Crystal Structure of the
Full-Length
Transglycosylase PBP1b
from Escherichia coli
http://www.rcsb.org/pdb/
explore/explore.do?
structureId=3VMA
Publicly available at RCSB
Protein Data Bank
(3VMA).
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 24 of 29
Research article Microbiology and infectious disease
Author(s) Year Dataset title
Dataset ID
and/or URL
Database, license, and
accessibility information
Krachler AM, Sharma A,
Cauldwell A, Papadakos
G, Kleanthous C
2010 Crystal structure of the
N-terminal domain of
E. coli YbgF
http://www.rcsb.org/pdb/
explore/explore.do?
structureId=2XDJ
Publicly available at RCSB
Protein Data Bank (2XDJ).
Krachler AM, Sharma A,
Cauldwell A, Papadakos
G, Kleanthous C
2010 Crystal structure of the
TPR domain of
Xanthomonas campestris
YbgF
http://www.rcsb.org/pdb/
explore/explore.do?
structureId=2XEV
Publicly available at RCSB
Protein Data Bank (2XEV).
Egan AJ, Jean NL,
Koumoutsi A, Bougault
CM, Biboy J, Sassine J,
Solovyova AS, Breukink E,
Typas A, Vollmer W,
Simorre JP
2014 NMR structure of E. coli
LpoB
http://www.rcsb.org/pdb/
explore/explore.do?
structureId=2MII
Publicly available at RCSB
Protein Data Bank (2MII).
References
Aarsman ME, Piette A, Fraipont C, Vinkenvleugel TM, Nguyen-Disteche M, den Blaauwen T. 2005. Maturation of
the Escherichia coli divisome occurs in two steps. Molecular Microbiology 55:1631–1645. doi: 10.1111/j.1365-
2958.2005.04502.x.
Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006.
Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Molecular
Systems Biology 2:2006 0008. doi: 10.1038/msb4100050.
Banzhaf M, van den Berg van Saparoea B, Terrak M, Fraipont C, Egan A, Philippe J, Zapun A, Breukink E, Nguyen-
Disteche M, den Blaauwen T, Vollmer W. 2012. Cooperativity of peptidoglycan synthases active in bacterial cell
elongation. Molecular Microbiology 85:179–194. doi: 10.1111/j.1365-2958.2012.08103.x.
Bernadac A, Gavioli M, Lazzaroni JC, Raina S, Lloubes R. 1998. Escherichia coli tol-pal mutants form outer
membrane vesicles. Journal of Bacteriology 180:4872–4878.
Bertsche U, Breukink E, Kast T, Vollmer W. 2005. In vitro murein peptidoglycan synthesis by dimers of the
bifunctional transglycosylase-transpeptidase PBP1B from Escherichia coli. The Journal of Biological Chemistry
280:38096–38101. doi: 10.1074/jbc.M508646200.
Bertsche U, Kast T, Wolf B, Fraipont C, Aarsman ME, Kannenberg K, von Rechenberg M, Nguyen-Disteche M, den
Blaauwen T, Ho¨ltje JV, Vollmer W. 2006. Interaction between two murein (peptidoglycan) synthases, PBP3 and
PBP1B, in Escherichia coli. Molecular Microbiology 61:675–690. doi: 10.1111/j.1365-2958.2006.05280.x.
Bi EF, Lutkenhaus J. 1991. FtsZ ring structure associated with division in Escherichia coli. Nature 354:161–164.
doi: 10.1038/354161a0.
Blomfield IC, Vaughn V, Rest RF, Eisenstein BI. 1991. Allelic exchange in Escherichia coli using the Bacillus subtilis
sacB gene and a temperature-sensitive pSC101 replicon. Molecular Microbiology 5:1447–1457. doi: 10.1111/j.
1365-2958.1991.tb00791.x.
Bonsor DA, Hecht O, Vankemmelbeke M, Sharma A, Krachler AM, Housden NG, Lilly KJ, James R, Moore GR,
Kleanthous C. 2009. Allosteric beta-propeller signalling in TolB and its manipulation by translocating colicins. The
EMBO Journal 28:2846–2857. doi: 10.1038/emboj.2009.224.
Born P, Breukink E, Vollmer W. 2006. In vitro synthesis of cross-linked murein and its attachment to sacculi by PBP1A
from Escherichia coli. The Journal of Biological Chemistry 281:26985–26993. doi: 10.1074/jbc.M604083200.
Breukink E, van Heusden HE, Vollmerhaus PJ, Swiezewska E, Brunner L, Walker S, Heck AJ, de Kruijff B. 2003. Lipid
II is an intrinsic component of the pore induced by nisin in bacterial membranes. The Journal of Biological
Chemistry 278:19898–19903. doi: 10.1074/jbc.M301463200.
Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M,
Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography & NMR system: a new software suite
for macromolecular structure determination. Acta Crystallographica. Section D, Biological Crystallography 54:
905–921. doi: 10.1107/S0907444998003254.
Buddelmeijer N, Aarsman M, den Blaauwen T. 2013. Immunolabeling of Proteins in situ in Escherichia coli K12
Strains. Bio-protocol 3:e852. http://www.bio-protocol.org/e852.
Cascales E, Bernadac A, Gavioli M, Lazzaroni JC, Lloubes R. 2002. Pal lipoprotein of Escherichia coli plays a major
role in outer membrane integrity. Journal of Bacteriology 184:754–759. doi: 10.1128/JB.184.3.754-759.2002.
Cascales E, Gavioli M, Sturgis JN, Lloubes R. 2000. Proton motive force drives the interaction of the inner
membrane TolA and outer membrane pal proteins in Escherichia coli. Molecular Microbiology 38:904–915.
doi: 10.1046/j.1365-2958.2000.02190.x.
Cascales E, Lloubes R, Sturgis JN. 2001. The TolQ-TolR proteins energize TolA and share homologies with the
flagellar motor proteins MotA-MotB. Molecular Microbiology 42:795–807. doi: 10.1046/j.1365-2958.2001.02673.x.
Chen JC, Beckwith J. 2001. FtsQ, FtsL and FtsI require FtsK, but not FtsN, for co-localization with FtsZ during
Escherichia coli cell division. Molecular Microbiology 42:395–413. doi: 10.1046/j.1365-2958.2001.02640.x.
Chin JW, Schultz PG. 2002. In vivo photocrosslinking with unnatural amino Acid mutagenesis. Chembiochem 3:
1135–1137. doi: 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M.
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 25 of 29
Research article Microbiology and infectious disease
Cho H, Uehara T, Bernhardt TG. 2014. Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell
wall synthesis machinery. Cell 159:1300–1311. doi: 10.1016/j.cell.2014.11.017.
Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR
products. Proceedings of the National Academy of Sciences of USA 97:6640–6645. doi: 10.1073/pnas.
120163297.
Datta S, Costantino N, Court DL. 2006. A set of recombineering plasmids for gram-negative bacteria. Gene 379:
109–115. doi: 10.1016/j.gene.2006.04.018.
de Vries SJ, van Dijk M, Bonvin AM. 2010. The HADDOCK web server for data-driven biomolecular docking.
Nature Protocols 5:883–897. doi: 10.1038/nprot.2010.32.
Demchick P, Koch AL. 1996. The permeability of the wall fabric of Escherichia coli and Bacillus subtilis. Journal of
Bacteriology 178:768–773.
den Blaauwen T, Aarsman ME, Vischer NO, Nanninga N. 2003. Penicillin-binding protein PBP2 of Escherichia coli
localizes preferentially in the lateral wall and at mid-cell in comparison with the old cell pole. Molecular
Microbiology 47:539–547. doi: 10.1046/j.1365-2958.2003.03316.x.
den Blaauwen T, Buddelmeijer N, Aarsman ME, Hameete CM, Nanninga N. 1999. Timing of FtsZ assembly in
Escherichia coli. Journal of Bacteriology 181:5167–5175.
Derouiche R, Be´ne´detti H, Lazzaroni JC, Lazdunski C, Lloube`s R. 1995. Protein complex within Escherichia coli
inner membrane. TolA N-terminal domain interacts with TolQ and TolR proteins. The Journal of Biological
Chemistry 270:11078–11084. doi: 10.1074/jbc.270.19.11078.
Dominguez C, Boelens R, Bonvin AM. 2003. HADDOCK: a protein-protein docking approach based on biochemical
or biophysical information. Journal of the American Chemical Society 125:1731–1737. doi: 10.1021/ja026939x.
Do¨rr T, Moll A, Chao MC, Cava F, Lam H, Davis BM, Waldor MK. 2014. Differential requirement for PBP1a and PBP1b
in in vivo and in vitro fitness of Vibrio cholerae. Infection and Immunity 82:2115–2124. doi: 10.1128/IAI.00012-14.
Edelstein A, Amodaj N, Hoover K, Vale R, Stuurman N. 2010. Computer control of microscopes using microManager.
Current Protocols in Molecular Biology. Chapter 14:Unit14 20. doi: 10.1002/0471142727.mb1420s92.
Egan AJF, Jean NL, Koumoutsi A, Bougault CM, Biboy J, Sassine J, Solovyova AS, Breukink E, Typas A, Vollmer W,
Simorre JP. 2014. Outer-membrane lipoprotein LpoB spans the periplasm to stimulate the peptidoglycan synthase
PBP1B. Proceedings of the National Academy of Sciences of USA 111:8197–8202. doi: 10.1073/pnas.1400376111.
Egan AJF, Vollmer W. 2013. The physiology of bacterial cell division. Annals of the New York Academy of Sciences
1277:8–28. doi: 10.1111/j.1749-6632.2012.06818.x.
Fraipont C, Alexeeva S, Wolf B, van der Ploeg R, Schloesser M, den Blaauwen T, Nguyen-Disteche M. 2011.
The integral membrane FtsW protein and peptidoglycan synthase PBP3 form a subcomplex in Escherichia coli.
Microbiology 157:251–259. doi: 10.1099/mic.0.040071-0.
Fung J, MacAlister TJ, Rothfield LI. 1978. Role of murein lipoprotein in morphogenesis of the bacterial division
septum: phenotypic similarity of lkyD and lpo mutants. Journal of Bacteriology 133:1467–1471.
Gan L, Chen S, Jensen GJ. 2008. Molecular organization of Gram-negative peptidoglycan. Proceedings of the
National Academy of Sciences of USA 105:18953–18957. doi: 10.1073/pnas.0808035105.
Garcia del Portillo F, de Pedro MA. 1990. Differential effect of mutational impairment of penicillin-binding
proteins 1A and 1B on Escherichia coli strains harboring thermosensitive mutations in the cell division genes ftsA,
ftsQ, ftsZ, and pbpB. Journal of Bacteriology 172:5863–5870.
Gerding MA, Ogata Y, Pecora ND, Niki H, de Boer PA. 2007. The trans-envelope Tol-Pal complex is part of the cell
division machinery and required for proper outer-membrane invagination during cell constriction in E. coli.
Molecular Microbiology 63:1008–1025. doi: 10.1111/j.1365-2958.2006.05571.x.
Germon P, Ray MC, Vianney A, Lazzaroni JC. 2001. Energy-dependent conformational change in the TolA protein
of Escherichia coli involves its N-terminal domain, TolQ, and TolR. Journal of Bacteriology 183:4110–4114.
doi: 10.1128/JB.183.14.4110-4114.2001.
Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation, modulation, and high-level expression by
vectors containing the arabinose PBAD promoter. Journal of Bacteriology 177:4121–4130.
Hantke K, Braun V. 1973. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the
N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. European Journal of
Biochemistry 34:284–296. doi: 10.1111/j.1432-1033.1973.tb02757.x.
Heckman KL, Pease LR. 2007. Gene splicing and mutagenesis by PCR-driven overlap extension. Nature Protocols
2:924–932. doi: 10.1038/nprot.2007.132.
Heidrich C, Templin MF, Ursinus A, Merdanovic M, Berger J, Schwarz H, de Pedro MA, Ho¨ltje JV. 2001.
Involvement of N-acetylmuramyl-L-alanine amidases in cell separation and antibiotic-induced autolysis of
Escherichia coli. Molecular Microbiology 41:167–178. doi: 10.1046/j.1365-2958.2001.02499.x.
Hocking J, Priyadarshini R, Takacs CN, Costa T, Dye NA, Shapiro L, Vollmer W, Jacobs-Wagner C. 2012.
Osmolality-dependent relocation of penicillin-binding protein PBP2 to the division site in Caulobacter crescentus.
Journal of Bacteriology 194:3116–3127. doi: 10.1128/JB.00260-12.
Ishino F, Jung HK, Ikeda M, Doi M, Wachi M, Matsuhashi M. 1989. New mutations fts-36, lts-33, and ftsW clustered
in the mra region of the Escherichia coli chromosome induce thermosensitive cell growth and division. Journal of
Bacteriology 171:5523–5530.
Jean NL, Bougault CM, Lodge A, Derouaux A, Callens G, Egan AJ, Ayala I, Lewis RJ, Vollmer W, Simorre JP. 2014.
Elongated structure of the outer-membrane activator of peptidoglycan synthesis LpoA: implications for PBP1A
stimulation. Structure 22:1047–1054. doi: 10.1016/j.str.2014.04.017.
Journet L, Rigal A, Lazdunski C, Benedetti H. 1999. Role of TolR N-terminal, central, and C-terminal domains in
dimerization and interaction with TolA and tolQ. Journal of Bacteriology 181:4476–4484.
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 26 of 29
Research article Microbiology and infectious disease
Kohlrausch U, Ho¨ltje JV. 1991. Analysis of murein and murein precursors during antibiotic-induced lysis of
Escherichia coli. Journal of Bacteriology 173:3425–3431.
Koppelman CM, Aarsman ME, Postmus J, Pas E, Muijsers AO, Scheffers DJ, Nanninga N, den Blaauwen T. 2004.
R174 of Escherichia coli FtsZ is involved in membrane interaction and protofilament bundling, and is essential for
cell division. Molecular Microbiology 51:645–657. doi: 10.1046/j.1365-2958.2003.03876.x.
Krachler AM, Sharma A, Cauldwell A, Papadakos G, Kleanthous C. 2010. TolA modulates the oligomeric
status of YbgF in the bacterial periplasm. Journal of Molecular Biology 403:270–285. doi: 10.1016/j.jmb.
2010.08.050.
Lazzaroni JC, Vianney A, Popot JL, Benedetti H, Samatey F, Lazdunski C, Portalier R, Geli V. 1995. Transmembrane
alpha-helix interactions are required for the functional assembly of the Escherichia coli Tol complex. Journal of
Molecular Biology 246:1–7. doi: 10.1006/jmbi.1994.0058.
Leisch N, Verheul J, Heindl NR, Gruber-Vodicka HR, Pende N, den Blaauwen T, Bulgheresi S. 2012. Growth in
width and FtsZ ring longitudinal positioning in a gammaproteobacterial symbiont. Current Biology 22:
R831–R832. doi: 10.1016/j.cub.2012.08.033.
Li GW, Burkhardt D, Gross C, Weissman JS. 2014. Quantifying absolute protein synthesis rates reveals principles
underlying allocation of cellular resources. Cell 157:624–635. doi: 10.1016/j.cell.2014.02.033.
Lloubes R, Cascales E, Walburger A, Bouveret E, Lazdunski C, Bernadac A, Journet L. 2001. The Tol-Pal proteins of
the Escherichia coli cell envelope: an energized system required for outer membrane integrity? Research in
Microbiology 152:523–529. doi: 10.1016/S0923-2508(01)01226-8.
Loose M, Mitchison TJ. 2014. The bacterial cell division proteins FtsA and FtsZ self-organize into dynamic
cytoskeletal patterns. Nature Cell Biology 16:38–46. doi: 10.1038/ncb2885.
Lupoli TJ, Lebar MD, Markovski M, Bernhardt T, Kahne D, Walker S. 2014. Lipoprotein activators stimulate
Escherichia coli penicillin-binding proteins by different mechanisms. Journal of the American Chemical Society
136:52–55. doi: 10.1021/ja410813j.
Lutje Hulsik D, Liu YY, Strokappe NM, Battella S, El Khattabi M, McCoy LE, Sabin C, Hinz A, Hock M, Macheboeuf
P, Bonvin AM, Langedijk JP, Davis D, Forsman Quigley A, Aasa-Chapman MM, Seaman MS, Ramos A, Poignard
P, Favier A, Simorre JP, Weiss RA, Verrips CT, Weissenhorn W, Rutten L. 2013. A gp41 MPER-specific llama VHH
requires a hydrophobic CDR3 for neutralization but not for antigen recognition. PLoS Pathogens 9:e1003202.
doi: 10.1371/journal.ppat.1003202.
MacAlister TJ, Cook WR, Weigand R, Rothfield LI. 1987. Membrane-murein attachment at the leading edge of the
division septum: a second membrane-murein structure associated with morphogenesis of the gram-negative
bacterial division septum. Journal of Bacteriology 169:3945–3951.
Matias VR, Al-Amoudi A, Dubochet J, Beveridge TJ. 2003. Cryo-transmission electron microscopy of frozen-
hydrated sections of Escherichia coli and Pseudomonas aeruginosa. Journal of Bacteriology 185:6112–6118.
doi: 10.1128/JB.185.20.6112-6118.2003.
Mohammadi T, Sijbrandi R, Lutters M, Verheul J, Martin NI, den Blaauwen T, de Kruijff B, Breukink E. 2014.
Specificity of the transport of lipid II by FtsW in Escherichia coli. The Journal of Biological Chemistry 289:
14707–14718. doi: 10.1074/jbc.M114.557371.
Muller P, Ewers C, Bertsche U, Anstett M, Kallis T, Breukink E, Fraipont C, Terrak M, Nguyen-Disteche M,
Vollmer W. 2007. The essential cell division protein FtsN interacts with the murein (peptidoglycan) synthase
PBP1B in Escherichia coli. The Journal of Biological Chemistry 282:36394–36402. doi: 10.1074/jbc.
M706390200.
Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass
spectrometry. Analytical Chemistry 75:4646–4658. doi: 10.1021/ac0341261.
Nichols RJ, Sen S, Choo YJ, Beltrao P, Zietek M, Chaba R, Lee S, Kazmierczak KM, Lee KJ, Wong A, Shales M,
Lovett S, Winkler ME, Krogan NJ, Typas A, Gross CA. 2011. Phenotypic landscape of a bacterial cell. Cell 144:
143–156. doi: 10.1016/j.cell.2010.11.052.
Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiology and Molecular
Biology Reviews 67:593–656. doi: 10.1128/MMBR.67.4.593-656.2003.
Nilsen T, Ghosh AS, Goldberg MB, Young KD. 2004. Branching sites and morphological abnormalities behave as
ectopic poles in shape-defective Escherichia coli. Molecular Microbiology 52:1045–1054. doi: 10.1111/j.1365-
2958.2004.04050.x.
Obermann W, Ho¨ltje JV. 1994. Alterations of murein structure and of penicillin-binding proteins in minicells from
Escherichia coli. Microbiology 140:79–87. doi: 10.1099/13500872-140-1-79.
Osawa M, Anderson DE, Erickson HP. 2009. Curved FtsZ protofilaments generate bending forces on liposome
membranes. The EMBO Journal 28:3476–3484. doi: 10.1038/emboj.2009.277.
Osawa M, Erickson HP. 2013. Liposome division by a simple bacterial division machinery. Proceedings of the
National Academy of Sciences of USA 110:11000–11004. doi: 10.1073/pnas.1222254110.
Paradis-Bleau C, Kritikos G, Orlova K, Typas A, Bernhardt TG. 2014. A genome-wide screen for bacterial envelope
biogenesis mutants identifies a novel factor involved in cell wall precursor metabolism. PLoS Genetics 10:
e1004056. doi: 10.1371/journal.pgen.1004056.
Paradis-Bleau C, Markovski M, Uehara T, Lupoli TJ, Walker S, Kahne DE, Bernhardt TG. 2010. Lipoprotein
cofactors located in the outer membrane activate bacterial cell wall polymerases. Cell 143:1110–1120. doi: 10.
1016/j.cell.2010.11.037.
Parsons LM, Lin F, Orban J. 2006. Peptidoglycan recognition by Pal, an outer membrane lipoprotein. Biochemistry
45:2122–2128. doi: 10.1021/bi052227i.
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 27 of 29
Research article Microbiology and infectious disease
Philippe N, Alcaraz JP, Coursange E, Geiselmann J, Schneider D. 2004. Improvement of pCVD442, a suicide
plasmid for gene allele exchange in bacteria. Plasmid 51:246–255. doi: 10.1016/j.plasmid.2004.02.003.
Potluri L, Karczmarek A, Verheul J, Piette A, Wilkin JM, Werth N, Banzhaf M, Vollmer W, Young KD, Nguyen-
Disteche M, den Blaauwen T. 2010. Septal and lateral wall localization of PBP5, the major D,D-carboxypeptidase
of Escherichia coli, requires substrate recognition and membrane attachment. Molecular Microbiology 77:
300–323. doi: 10.1111/j.1365-2958.2010.07205.x.
Radolf JD, Caimano MJ, Stevenson B, Hu LT. 2012. Of ticks, mice and men: understanding the dual-host lifestyle of
Lyme disease spirochaetes. Nature Reviews. Microbiology 10:87–99. doi: 10.1038/nrmicro2714.
Ryu Y, Schultz PG. 2006. Efficient incorporation of unnatural amino acids into proteins in Escherichia coli. Nature
Methods 3:263–265. doi: 10.1038/nmeth864.
Schneider T, Sahl HG. 2010. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
International Journal of Medical Microbiology 300:161–169. doi: 10.1016/j.ijmm.2009.10.005.
Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. 2006. In-gel digestion for mass spectrometric
characterization of proteins and proteomes. Nature Protocols 1:2856–2860. doi: 10.1038/nprot.2006.468.
Sung MT, Lai YT, Huang CY, Chou LY, Shih HW, Cheng WC, Wong CH, Ma C. 2009. Crystal structure of the
membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli. Proceedings of the National
Academy of Sciences of USA 106:8824–8829. doi: 10.1073/pnas.0904030106.
Szwedziak P, Wang Q, Bharat TA, Tsim M, Lo¨we J. 2014. Architecture of the ring formed by the tubulin
homologue FtsZ in bacterial cell division. Elife 3:e04601. doi: 10.7554/eLife.04601.
Szwedziak P, Wang Q, Freund SM, Lo¨we J. 2012. FtsA forms actin-like protofilaments. The EMBO Journal 31:
2249–2260. doi: 10.1038/emboj.2012.76.
Taschner PE, Huls PG, Pas E, Woldringh CL. 1988. Division behavior and shape changes in isogenic ftsZ, ftsQ, ftsA,
pbpB, and ftsE cell division mutants of Escherichia coli during temperature shift experiments. Journal of
Bacteriology 170:1533–1540.
Terrak M, Ghosh TK, van Heijenoort J, Van Beeumen J, Lampilas M, Aszodi J, Ayala JA, Ghuysen JM, Nguyen-
Disteche M. 1999. The catalytic, glycosyl transferase and acyl transferase modules of the cell wall peptidoglycan-
polymerizing penicillin-binding protein 1b of Escherichia coli. Molecular Microbiology 34:350–364. doi: 10.1046/
j.1365-2958.1999.01612.x.
Thomason LC, Costantino N, Court DL. 2007. E. coli genome manipulation by P1 transduction. Current Protocols in
Molecular Biology. Chapter 1:Unit 1 17. doi: 10.1002/0471142727.mb0117s79.
Thomason LC, Sawitzke JA, Li X, Costantino N, Court DL. 2014. Recombineering: genetic engineering in bacteria
using homologous recombination. Current Protocols in Molecular Biology 106:1.16.1–1.16.39. doi: 10.1002/
0471142727.mb0116s106.
Typas A, Banzhaf M, Gross CA, Vollmer W. 2012. From the regulation of peptidoglycan synthesis to bacterial
growth and morphology. Nature Reviews. Microbiology 10:123–136. doi: 10.1038/nrmicro2677.
Typas A, Banzhaf M, van den Berg van Saparoea B, Verheul J, Biboy J, Nichols RJ, Zietek M, Beilharz K,
Kannenberg K, von Rechenberg M, Breukink E, den Blaauwen T, Gross CA, Vollmer W. 2010.
Regulation of peptidoglycan synthesis by outer-membrane proteins. Cell 143:1097–1109. doi: 10.1016/j.
cell.2010.11.038.
Uehara T, Dinh T, Bernhardt TG. 2009. LytM-domain factors are required for daughter cell separation and
rapid ampicillin-induced lysis in Escherichia coli. Journal of Bacteriology 191:5094–5107. doi: 10.1128/JB.
00505-09.
Uehara T, Parzych KR, Dinh T, Bernhardt TG. 2010. Daughter cell separation is controlled by cytokinetic ring-
activated cell wall hydrolysis. The EMBO Journal 29:1412–1422. doi: 10.1038/emboj.2010.36.
Ursell TS, Nguyen J, Monds RD, Colavin A, Billings G, Ouzounov N, Gitai Z, Shaevitz JW, Huang KC. 2014. Rod-like
bacterial shape is maintained by feedback between cell curvature and cytoskeletal localization. Proceedings of
the National Academy of Sciences of USA 111:E1025–E1034. doi: 10.1073/pnas.1317174111.
van der Ploeg R, Verheul J, Vischer NO, Alexeeva S, Hoogendoorn E, Postma M, Banzhaf M, Vollmer W, den
Blaauwen T. 2013. Colocalization and interaction between elongasome and divisome during a preparative cell
division phase in Escherichia coli. Molecular Microbiology 87:1074–1087. doi: 10.1111/mmi.12150.
Vazquez-Laslop N, Lee H, Hu R, Neyfakh AA. 2001. Molecular sieve mechanism of selective release of cytoplasmic
proteins by osmotically shocked Escherichia coli. Journal of Bacteriology 183:2399–2404. doi: 10.1128/JB.183.8.
2399-2404.2001.
Vianney A, Muller MM, Clavel T, Lazzaroni JC, Portalier R, Webster RE. 1996. Characterization of the tol-pal region
of Escherichia coli K-12: translational control of tolR expression by TolQ and identification of a new open reading
frame downstream of pal encoding a periplasmic protein. Journal of Bacteriology 178:4031–4038.
Vollmer W, Blanot D, de Pedro MA. 2008. Peptidoglycan structure and architecture. FEMS Microbiology Reviews
32:149–167. doi: 10.1111/j.1574-6976.2007.00094.x.
Vollmer W, von Rechenberg M, Ho¨ltje JV. 1999. Demonstration of molecular interactions between the murein
polymerase PBP1B, the lytic transglycosylase MltA, and the scaffolding protein MipA of Escherichia coli. The
Journal of Biological Chemistry 274:6726–6734. doi: 10.1074/jbc.274.10.6726.
Wagner JK, Heindl JE, Gray AN, Jain S, Goldberg MB. 2009. Contribution of the periplasmic chaperone Skp to
efficient presentation of the autotransporter IcsA on the surface of Shigella flexneri. Journal of Bacteriology 191:
815–821. doi: 10.1128/JB.00989-08.
Weigand RA, Vinci KD, Rothfield LI. 1976. Morphogenesis of the bacterial division septum: a new class of
septation-defective mutants. Proceedings of the National Academy of Sciences of USA 73:1882–1886. doi: 10.
1073/pnas.73.6.1882.
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 28 of 29
Research article Microbiology and infectious disease
Weiss DS. 2015. Last but not least: new insights into how FtsN triggers constriction during Escherichia coli cell
division. Molecular Microbiology 95:903–909. doi: 10.1111/mmi.12925.
Yang DC, Peters NT, Parzych KR, Uehara T, Markovski M, Bernhardt TG. 2011. An ATP-binding cassette
transporter-like complex governs cell-wall hydrolysis at the bacterial cytokinetic ring. Proceedings of the National
Academy of Sciences of USA 108:E1052–E1060. doi: 10.1073/pnas.1107780108.
Yousif SY, Broome-Smith JK, Spratt BG. 1985. Lysis of Escherichia coli by beta-lactam antibiotics: deletion analysis
of the role of penicillin-binding proteins 1A and 1B. Journal of General Microbiology 131:2839–2845.
Gray et al. eLife 2015;4:e07118. DOI: 10.7554/eLife.07118 29 of 29
Research article Microbiology and infectious disease
